{
  "meta": {
    "title": "Biochemistry_Test",
    "url": "https://brainandscalpel.vercel.app/biochemistry-test-e5d04bfb.html",
    "scrapedAt": "2025-11-30T12:49:13.288Z"
  },
  "questions": [
    {
      "text": "Match the following substances with their Respiratory quotient<div class='question-desc-html'><table>\n<tbody>\n<tr>\n<td>1. Carbohydrates</td>\n<td>A. 0.8</td>\n</tr>\n<tr>\n<td>2. Fats</td>\n<td>B. 1</td>\n</tr>\n<tr>\n<td>3. Proteins</td>\n<td>C. 0.85</td>\n</tr>\n<tr>\n<td>4. Mixed diet</td>\n<td>D. 0.7</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div></div>",
      "choices": [
        {
          "id": 1,
          "text": "1-B, 2-D, 3-A, 4-C"
        },
        {
          "id": 2,
          "text": "1-B, 2-D, 3-C, 4-A"
        },
        {
          "id": 3,
          "text": "1-A, 2-C, 3-B, 4-D"
        },
        {
          "id": 4,
          "text": "1-A, 2-C, 3-D, 4-B"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<div class=\"page\" title=\"Page 833\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">&nbsp;</div>\n</div>\n</div>\n</div>\n<div class=\"page\" title=\"Page 544\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>The correct match is</p>\n<table>\n<tbody>\n<tr>\n<td>1. Carbohydrates</td>\n<td>B. 1</td>\n</tr>\n<tr>\n<td>2. Fats</td>\n<td>D. 0.7</td>\n</tr>\n<tr>\n<td>3. Proteins</td>\n<td>A. 0.8</td>\n</tr>\n<tr>\n<td>4. Mixed diet</td>\n<td>C. 0.85</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>Respiratory quotient (RQ) is defined as the <strong>ratio</strong> of the<strong> volume of CO2 produced in L/g to the oxygen consumed in L/g.</strong></p>\n</div>\n</div>\n</div>\n</div>\n<p>The<strong>&nbsp;respiratory quotient&nbsp;</strong>for various substances:</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Substance</strong></td>\n<td><strong>RQ</strong></td>\n</tr>\n<tr>\n<td>Carbohydrate</td>\n<td>1</td>\n</tr>\n<tr>\n<td>Protein</td>\n<td>0.8</td>\n</tr>\n<tr>\n<td>Fat&nbsp;</td>\n<td>0.7</td>\n</tr>\n<tr>\n<td>Alcohol</td>\n<td>0.66&nbsp;</td>\n</tr>\n<tr>\n<td>Mixed diet</td>\n<td>0.82-0.85</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>In diabetes, the rate of utilization of carbohydrates reduces in relation to fats, hence RQ falls (approximately 0.7). The RQ is lowest when ketosis is very active.</p>\n<p>Note: For all metabolic fuels, the <strong>energy</strong> produced is the same (<strong>20 kJ/L of oxygen</strong>).</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF9591",
      "difficulty": "easy"
    },
    {
      "text": "Match the following glucose transporters with their location.<div class='question-desc-html'><table>\n<tbody>\n<tr>\n<td><strong>GLUCOSE TRANSPORTER</strong></td>\n<td><strong>LOCATION</strong></td>\n</tr>\n<tr>\n<td>A. GLUT 1</td>\n<td>1. Sperm</td>\n</tr>\n<tr>\n<td>B. GLUT 2</td>\n<td>2. Heart</td>\n</tr>\n<tr>\n<td>C. GLUT 3</td>\n<td>3. Neurons</td>\n</tr>\n<tr>\n<td>D. GLUT 4</td>\n<td>4. Liver</td>\n</tr>\n<tr>\n<td>E. GLUT 5</td>\n<td>5. RBC</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div></div>",
      "choices": [
        {
          "id": 1,
          "text": "A-1, B-2, C-3, D-4, E-5"
        },
        {
          "id": 2,
          "text": "A-2, B-3, C-4, D-1, E-5"
        },
        {
          "id": 3,
          "text": "A-5. B-4, C-3, D-1, E-2"
        },
        {
          "id": 4,
          "text": "A-5, B-4, C-3, D-2, E-1"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The correct match is</p>\n<table>\n<tbody>\n<tr>\n<td><strong>GLUCOSE TRANSPORTER</strong></td>\n<td><strong>LOCATION</strong></td>\n</tr>\n<tr>\n<td>A. GLUT 1</td>\n<td>5. RBC</td>\n</tr>\n<tr>\n<td>B. GLUT 2</td>\n<td>4. Liver</td>\n</tr>\n<tr>\n<td>C. GLUT 3</td>\n<td>3. Neurons</td>\n</tr>\n<tr>\n<td>D. GLUT 4</td>\n<td>2. Heart</td>\n</tr>\n<tr>\n<td>E. GLUT 5</td>\n<td>1. Sperm</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p> </p><hr><h3>Related Pearl: Glucose transporters and their locations</h3><table>\n<tbody>\n<tr>\n<td><strong>Tissue location</strong></td>\n<td><strong>Function</strong></td>\n</tr>\n<tr>\n<td><strong>GLUT 1</strong></td>\n</tr>\n<tr>\n<td><strong>Brain, RBC, Placenta</strong>, kidney, colon</td>\n<td>Basal glucose uptake</td>\n</tr>\n<tr>\n<td><strong>GLUT 2</strong></td>\n</tr>\n<tr>\n<td><strong>Liver</strong>, pancreatic beta cell, small intestine, kidney</td>\n<td>Rapid uptake/release of glucose. Low affinity and high km</td>\n</tr>\n<tr>\n<td><strong>GLUT 3</strong></td>\n</tr>\n<tr>\n<td><strong>Neurons</strong>, kidney, placenta</td>\n<td>High affinity for glucose</td>\n</tr>\n<tr>\n<td><strong>GLUT 4</strong></td>\n</tr>\n<tr>\n<td>Heart, skeletal muscle, adipose tissue</td>\n<td>Insulin-dependent glucose uptake</td>\n</tr>\n<tr>\n<td><strong>GLUT 5</strong></td>\n</tr>\n<tr>\n<td>Small intestine, testis, sperm</td>\n<td><strong>Fructose transporter</strong></td>\n</tr>\n<tr>\n<td><strong>GLUT 8</strong></td>\n</tr>\n<tr>\n<td><strong>Blastocyst</strong>, testis, brain</td>\n<td>Insulin-dependent glucose uptake in blastocyst. Transports glucose to Mature spermatozoa.</td>\n</tr>\n<tr>\n<td><strong>GLUT 9</strong></td>\n</tr>\n<tr>\n<td>Liver, kidney</td>\n<td><strong>Urate transporter</strong></td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD9837",
      "difficulty": "easy"
    },
    {
      "text": "What is the location of the complexes shown in the image below?",
      "choices": [
        {
          "id": 1,
          "text": "Inner mitochondrial membrane"
        },
        {
          "id": 2,
          "text": "Outer mitochondrial membrane"
        },
        {
          "id": 3,
          "text": "Mitochondrial matrix"
        },
        {
          "id": 4,
          "text": "Intermembrane space"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The image shows the&nbsp;<strong>electron transport chain </strong>(ETC) which is located on the&nbsp;<strong>inner mitochondrial membrane.&nbsp;</strong></p>\n<p>The <strong>electron transport chain </strong>(ETC)&nbsp;is a specialized set of electron carriers that can accept electrons. Energy-rich molecules like glucose are oxidized to produce water and carbon dioxide. The intermediate substrates in these reactions can pass on electrons to certain <strong>coenzymes</strong>&nbsp;like nicotinamide adenine dinucleotide (<strong>NAD<sup>+</sup></strong>) and flavin adenine dinucleotide (<strong>FADH2</strong>). The reduced forms can then donate electrons to the ETC by which they lose most of their free energy which is used to move H<sup>+</sup> through the inner mitochondrial membrane. The <strong>H+ gradient</strong> thus produced results in the production of ATP. <strong>ATP synthesis</strong> together with electron transport is known as <strong>oxidative phosphorylation</strong>.&nbsp;</p>\n<p>Option B -&nbsp;<strong>Outer mitochondrial membrane</strong> has acyl-CoA synthetase and glycerol phosphate acyltransferase.</p>\n<p>Option C -&nbsp;<strong>Mitochondrial matrix</strong> has citric acid cycle enzymes, &beta;-oxidation enzymes, and pyruvate dehydrogenase.</p>\n<p>Option D -&nbsp;<strong>Intermembrane space</strong> has adenylyl kinase and creatine kinase.</p>\n<p>&nbsp;The reactions in oxidative phosphorylation and the arrangement of complexes that form the ETC are shown below.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/4b1c9b24fcdb4c51b96ed9c5caa12a43x1280x2560.JPEG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Electron transport chain: components and its inhibitors</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/bcc617cb8a8343ff8c0208d7726a0ba7x1280x1468.JPEG\" alt=\"Pearl Image\"><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/c87ed88288804113994e57192a28d6f8x1280x969.JPEG\" alt=\"Pearl Image\"><hr><h3>Related Pearl: Reducing Equivalents and Their Uses</h3><table>\n<tbody>\n<tr>\n<td>\n<p>Reducing agents</p>\n</td>\n<td>\n<p>Uses</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>NADPH</p>\n</td>\n<td>\n<p>Lipid synthesis</p>\n<p>Cholesterol synthesis&nbsp;</p>\n<p>Fatty acid chain elongation</p>\n<p>Cytochrome P450&nbsp;hydroxylation&nbsp;of&nbsp;aromatic compounds, steroids,&nbsp;alcohols, and&nbsp;drugs</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>NADH</p>\n</td>\n<td>\n<p>Metabolizes alcohol</p>\n<p>Glycolysis &amp; Krebs cycle</p>\n<p>Oxidative phosphorylation</p>\n<p>&beta;- Oxidation of fatty acid</p>\n<p>Catalyzes reactions in muscle and liver cells</p>\n<p>Electron Transport Chain</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>FADH<sub>2</sub></p>\n</td>\n<td>\n<p>Krebs cycle</p>\n<p>Electron Transport Chain</p>\n<p>Oxidative Phosphorylation</p>\n<p>Cytochrome P450 hydroxylase cycle</p>\n<p>&beta;-Oxidation of fatty acid</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/67a6b8483ce04eaa9f38019b0b9f455a.PNG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF6332",
      "difficulty": "easy"
    },
    {
      "text": "A father has noticed that whenever his daughter drinks fruit juice, she has multiple episodes of vomiting. He reports to you that his daughter is allergic to fruit juice. After a thorough workup, she was diagnosed to have aldolase B deficiency. Which of the following substrate is accumulated in the blood?",
      "choices": [
        {
          "id": 1,
          "text": "Fructose-1-phosphate"
        },
        {
          "id": 2,
          "text": "Fructose-6-phosphate"
        },
        {
          "id": 3,
          "text": "Glyceraldehyde 3 phosphate"
        },
        {
          "id": 4,
          "text": "Glycerol"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The substrate accumulated in the blood in <strong>aldolase B deficiency</strong> is&nbsp;<strong>fructose-1-phosphate.&nbsp;</strong></p>\n<p>Aldolase B is also known as fructose-1-phosphate aldolase. It is involved in the<strong> breakdown </strong>of <strong>fructose-1-phosphate </strong>into <strong>glyceraldehyde </strong>and <strong>DHAP.</strong> Deficiency of this enzyme leads to the accumulation of fructose-1-phosphate and leads to hereditary fructose intolerance.</p>\n<p><strong>Hereditary fructose intolerance (HFI)</strong>&nbsp;is due to a&nbsp;<strong>deficiency </strong>of the enzyme<strong> aldolase</strong> <strong>B</strong>. It is an <strong>autosomal recessive</strong> inborn error of metabolism. This occurs when <strong>sucrose</strong> (containing fructose) is <strong>introduced into the diet of infants</strong>, usually around 6 months of age.</p>\n<p>Defective aldolase B causes the <strong>accumulation</strong> <strong>of</strong> <strong>fructose-1-phosphate. </strong>This will <strong>inhibit glycogen phosphorylase&nbsp;</strong>and cause accumulation&nbsp;of glycogen in the liver and associated hypoglycemia<strong>. </strong>Patients will present with vomiting, loss of appetite, and failure to thrive. Hepatomegaly and jaundice may occur. If liver damage progresses, death will occur.&nbsp;</p>\n<p><strong>Reducing substance</strong> is seen in the <strong>urine</strong> <strong>during </strong>an<strong> episode</strong> (<strong>Benedict's test +</strong>).</p>\n<p>Treatment is by the <strong>complete elimination</strong> of all sources <strong>of sucrose, fructose, and sorbitol </strong>from the diet.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/5f39f85ceb46421fbc5a2811f429bb43x1280x1703.JPEG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC1110",
      "difficulty": "medium"
    },
    {
      "text": "An investigator was studying the effects of various poisons on the enzymes of the glycolytic pathway. He plotted the graph for the enzyme catalyzing the conversion of phosphoenolpyruvate to pyruvate after adding alanine, which is a non-competitive inhibitor. Which of the following graphs shows the effect caused by alanine?",
      "choices": [
        {
          "id": 1,
          "text": "The type of plot will depend on the relative concentration of alanine and enzyme."
        },
        {
          "id": 2,
          "text": "B"
        },
        {
          "id": 3,
          "text": "A"
        },
        {
          "id": 4,
          "text": "C"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><span data-preserver-spaces=\"true\">Graph C represents&nbsp;</span><strong><span data-preserver-spaces=\"true\">non</span></strong><span data-preserver-spaces=\"true\">-</span><strong><span data-preserver-spaces=\"true\">competitive inhibition.</span></strong><span data-preserver-spaces=\"true\">&nbsp;The inhibition of pyruvate kinase by alanine is an example of non-competitive inhibition.</span></p>\n<p><span data-preserver-spaces=\"true\">Non-competitive inhibition: When the <strong>substrate</strong> and the <strong>inhibitor</strong> are <strong>chemically not similar</strong> and have different shapes, the <strong>inhibitor binds away</strong> from the <strong>active</strong> <strong>site</strong>, i.e., at the allosteric site. This type of inhibition is known as non-competitive inhibition.</span></p>\n<p><span data-preserver-spaces=\"true\">In non-competitive inhibition,</span></p>\n<ul>\n<li><span data-preserver-spaces=\"true\">V<sub>max</sub> decreases.</span></li>\n<li><span data-preserver-spaces=\"true\">K<sub>m</sub> remains constant.</span></li>\n</ul>\n<p><span data-preserver-spaces=\"true\">In a Lineweaver-Burk Plot, the addition of a non-competitive inhibitor causes plots with the <strong>same x-intercept</strong> (K<sub>m</sub> is unaffected) but <strong>different</strong> <strong>slopes</strong> and <strong>y-intercepts</strong>.</span></p>\n<p><span data-preserver-spaces=\"true\">Lineweaver-Burk plot is also known as the<strong> d</strong></span><strong>ouble reciprocal plot.</strong></p>\n<div class=\"page\" title=\"Page 67\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Competitive inhibition</strong> (graph A) - Here, the&nbsp;<strong>inhibitor</strong> is a <strong>structural analog</strong> of the <strong>substrate</strong>. Inhibitor molecules are competing with the normal substrate molecules for binding to the active site of the enzyme.</p>\n</div>\n</div>\n</div>\n<p><strong>Uncompetitive inhibition </strong>(graph B) - Here, the inhibitor<strong> does not</strong> have any <strong>affinity</strong> for the <strong>free</strong> <strong>enzyme</strong>. The <strong>inhibitor binds</strong> to the <strong>enzyme-substrate</strong> complex, but not to the free enzyme. Here, both <strong>V<sub>max</sub></strong> and <strong>K<sub>m</sub></strong> are <strong>decreased</strong>. Inhibition of <strong>placental alkaline phosphatase</strong> (Regan isoenzyme) by <strong>phenylalanine</strong> is an example of uncompetitive inhibition.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/49fa94db401242a09b3be62893ae138cx962x377.PNG\" alt=\"Explanation Image\"><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/3a9939405c0c45589cb2df5ba8e1e567x1280x2317.JPEG\" alt=\"Explanation Image\"><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/3de90a9c0df54c54a8ae9e13867d5fb3x1280x2235.JPEG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Difference between Competitive & Non-Competitive inhibitors</h3><p>Reversible inhibitors are of two types:</p>\n<ul>\n<li>Competitive inhibitors</li>\n<li>Non-Competitive inhibitors</li>\n</ul>\n<p>Difference between Competitive &amp; Non-Competitive inhibitors</p>\n<table>\n<tbody>\n<tr>\n<td>\n<p><strong>Competitive inhibitors</strong></p>\n</td>\n<td>\n<p><strong>Non-Competitive inhibitors</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Succinate dehydrogenase is inhibited by Malonate</p>\n</td>\n<td>\n<p>Pyruvate kinase is inhibited by alanine</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Substrate &amp; inhibitor are chemically similar &amp; have same shape</p>\n</td>\n<td>\n<p>Substrate &amp; inhibitor are chemically not similar &amp; have different shape</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Inhibitor binds to active site</p>\n</td>\n<td>\n<p>Inhibitor binds away from active site, i.e., at allosteric site</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Inhibitor does not change the shape of the active site</p>\n</td>\n<td>\n<p>Inhibitor changes the shape of the active site</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Increase in substrate concentration reduces the inhibition</p>\n</td>\n<td>\n<p>Increase in substrate concentration does not affect the inhibition</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Vmax remains constant</p>\n</td>\n<td>\n<p>Vmax decreases</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Km Increases</p>\n</td>\n<td>\n<p>Km remains constant</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/13d726643dd244b4b82747378512d163.PNG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD4085",
      "difficulty": "easy"
    },
    {
      "text": "In a sample of DNA if adenine is 23%, what will be the amount of guanine?",
      "choices": [
        {
          "id": 1,
          "text": "27%"
        },
        {
          "id": 2,
          "text": "23%"
        },
        {
          "id": 3,
          "text": "46%"
        },
        {
          "id": 4,
          "text": "54%"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>In a sample of DNA, if adenine is 23%, <strong>guanine will be 27%.</strong></p>\n<p>This is based on Chargaff&rsquo;s rule which states that the number of purines is equal to the number of pyrimidines.</p>\n<p><strong>Purines</strong> include <strong>adenine and guanine</strong>. <strong>Pyrimidines</strong> include<strong> thymine and cytosine. </strong>The <span>two strands of DNA are complementary to each other. </span><span>So, the<strong> adenine</strong> of one strand will <strong>pair with thymine</strong> of the opposite strand, while<strong> guanine will pair with cytosine</strong>.</span></p>\n<ul>\n<li>Step 1:</li>\n</ul>\n<p>No of adenine = No of thymine</p>\n<p>So adenine + thymine = 46%</p>\n<p>Guanine + cytosine = 54%</p>\n<ul>\n<li>Step 2:</li>\n</ul>\n<p>No of guanine = No of cytosine</p>\n<p>So, amount of guanine = 54/2 = 27%</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC5034",
      "difficulty": "easy"
    },
    {
      "text": "The absorption spectrum given in the image below belongs to which of the following?",
      "choices": [
        {
          "id": 1,
          "text": "NADH"
        },
        {
          "id": 2,
          "text": "Tryptophan"
        },
        {
          "id": 3,
          "text": "DNA"
        },
        {
          "id": 4,
          "text": "Porphyrins"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The absorption spectrum given in the image below shows increased absorption at <strong>400nm. Porphyrins&nbsp;</strong>absorb UV light at 400nm.</p>\n<p><strong>Conjugated double bonds</strong> in the porphyrin rings absorb light at the UV spectrum. The maximum absorbance of porphyrins is around <strong>400 nm. </strong>This peak is known as <strong>Soret band.</strong></p>\n<p>The <strong>conjugated double bonds </strong>in the pyrrole rings and linking methylene groups of porphyrins (absent in the porphyrinogens) are responsible for their characteristic absorption and fluorescence spectra.</p>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/583c3473ef9a4b18b98efd5500817235.PNG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB8790",
      "difficulty": "medium"
    },
    {
      "text": "Match the following eukaryotic DNA polymerases with their functions.<div class='question-desc-html'><table>\n<tbody>\n<tr>\n<td><strong>DNA polymerase</strong></td>\n<td><strong>Function</strong></td>\n</tr>\n<tr>\n<td>1. Alpha</td>\n<td>A. Mitochondrial DNA synthesis</td>\n</tr>\n<tr>\n<td>2. Beta</td>\n<td>B.&nbsp;Primase</td>\n</tr>\n<tr>\n<td>3. Gamma</td>\n<td>C.&nbsp;DNA repair</td>\n</tr>\n<tr>\n<td>4. Delta</td>\n<td>D.&nbsp;Processive, leading strand synthesis</td>\n</tr>\n<tr>\n<td>&nbsp;</td>\n<td>E.&nbsp;Processive, lagging strand synthesis</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div></div>",
      "choices": [
        {
          "id": 1,
          "text": "1-A, 2-B, 3-C, 4-D"
        },
        {
          "id": 2,
          "text": "1-B, 2-C, 3-A, 4-E"
        },
        {
          "id": 3,
          "text": "1-C, 2-D, 3-E, 4-B"
        },
        {
          "id": 4,
          "text": "1- D, 2-A, 3-B, 4-C"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The correct match is<strong> 1-B, 2-C, 3-A, and 4-E.</strong></p>\n<table>\n<tbody>\n<tr>\n<td><strong>DNA polymerase</strong></td>\n<td><strong>Function</strong></td>\n</tr>\n<tr>\n<td>1. Alpha</td>\n<td>B. Primase</td>\n</tr>\n<tr>\n<td>2. Beta</td>\n<td>C.&nbsp;DNA repair</td>\n</tr>\n<tr>\n<td>3. Gamma</td>\n<td>A. Mitochondrial DNA synthesis</td>\n</tr>\n<tr>\n<td>4. Delta</td>\n<td>E.&nbsp;Processive, lagging strand synthesis</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/7f556b62fe574fe0ae33cf5fa1159019x980x1232.PNG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Enzymes Involved in DNA Replication</h3><p>Prokaryotic DNA replication enzymes and their function:</p>\n<table>\n<tbody>\n<tr>\n<td>Enzyme</td>\n<td>Function</td>\n</tr>\n<tr>\n<td>DNA Polymerase I (Pol I)</td>\n<td>Gap filling following DNA replication, repair, and recombination</td>\n</tr>\n<tr>\n<td>DNA polymerase II (Pol II)</td>\n<td>DNA proofreading and repair</td>\n</tr>\n<tr>\n<td>DNA polymerase III (Pol III)</td>\n<td>\n<p>Processive, leading strand synthesis, DNA proofreading</p>\n</td>\n</tr>\n<tr>\n<td>DnaG</td>\n<td>\n<p>Primase&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>Helicase</td>\n<td>ATP-driven processive unwinding of DNA.</td>\n</tr>\n<tr>\n<td>Primase</td>\n<td>Initiates synthesis of RNA primers.</td>\n</tr>\n<tr>\n<td>Topoisomerase</td>\n<td>Relieve torsional strain that results from helicase-induced unwinding.</td>\n</tr>\n<tr>\n<td>Single-strand binding proteins (SSBs)</td>\n<td>Prevents premature reannealing of dsDNA.</td>\n</tr>\n<tr>\n<td>DNA ligase</td>\n<td>Seals the single strand nick between the nascent chain and Okazaki fragments on lagging strand.</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>\n<p>Eukaryotic DNA polymerases:</p>\n<table>\n<tbody>\n<tr>\n<td>Eukaryotic DNA Polymerases</td>\n<td>Functions</td>\n<td>Proofreading</td>\n</tr>\n<tr>\n<td>&alpha;&nbsp;</td>\n<td>Primase (initiates DNA synthesis)</td>\n<td>-</td>\n</tr>\n<tr>\n<td><em>&beta;</em></td>\n<td>DNA repair</td>\n<td>-</td>\n</tr>\n<tr>\n<td>\n<p>&gamma;</p>\n</td>\n<td>Mitochondrial DNA synthesis</td>\n<td>+</td>\n</tr>\n<tr>\n<td>&nbsp;&delta;&nbsp;</td>\n<td>Processive, lagging strand synthesis(forms and elongates Okazaki fragments from primer)</td>\n<td>+</td>\n</tr>\n<tr>\n<td>&nbsp;<em>&epsilon;&nbsp;</em></td>\n<td>Processive, leading strand synthesis</td>\n<td>+</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF0665",
      "difficulty": "easy"
    },
    {
      "text": "In the lac operon model, a high level of transcription takes place only when____",
      "choices": [
        {
          "id": 1,
          "text": "Both Glucose and Lactose are present"
        },
        {
          "id": 2,
          "text": "Glucose is present and Lactose is absent"
        },
        {
          "id": 3,
          "text": "Both Glucose and Lactose are absent"
        },
        {
          "id": 4,
          "text": "Glucose is absent and Lactose is present"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>In the <strong>lac operon model</strong>, a <strong>high</strong> level of <strong>transcription</strong> takes place only when <strong>Glucose</strong> is <strong>absent</strong> and <strong>lactose</strong> is <strong>present</strong>.</p>\n<p>Lac operon is an operon required for the transport and metabolism of lactose in E. coli and some other enteric bacteria.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/32dd743e72b445cf9fc8701a66d43410x575x441.PNG\" alt=\"Explanation Image\"><p><strong>Lac operon concept</strong></p>\n<p><span class=\"Apple-converted-space\"><strong>Lac operon model - </strong>It&nbsp;is the </span>regulation of&nbsp;<strong>lactose metabolism</strong>&nbsp;by the intestinal bacterium&nbsp;<em><strong>E. coli</strong></em>.<span class=\"Apple-converted-space\"> It is switched on when the bacteria have to utilize lactose. Otherwise, it is switched off. </span>The genetic arrangement of the lac operon helps coordinate the expression of the<strong>&nbsp;three main enzymes&nbsp;</strong>(5, 6, 7 below) involved in&nbsp;<strong>lactose</strong>&nbsp;metabolism. The genes include:</p>\n<ol>\n<li><span class=\"Apple-converted-space\"><strong>lac I </strong>- It codes for the repressor protein that </span>prevents transcription of the distal structural genes, lac Z, lac Y, and lac A by interfering with the binding of RNA polymerase to the promoter.</li>\n<li><span class=\"Apple-converted-space\"><strong>CRE&nbsp;</strong>(cAMP response element)- It is activated by binding the&nbsp;</span>cyclic AMP activator protein (CAP). When activated, it increases the binding of&nbsp;RNA polymerase<span class=\"Apple-converted-space\">&nbsp;and increases gene expression.</span></li>\n<li><span class=\"Apple-converted-space\"><strong>Promoter site</strong>- It is the site where RNA polymerase binds the gene for transcription.&nbsp;</span></li>\n<li><span class=\"Apple-converted-space\"><strong>Operator site</strong>- It is the site where repressor protein binds.</span></li>\n<li><span class=\"Apple-converted-space\"><strong>lac Z gene</strong>- It codes for&nbsp;</span><strong>&beta;-Galactosidase</strong>&nbsp;that hydrolyzes lactose to galactose and glucose.<span class=\"Apple-converted-space\">&nbsp;</span></li>\n<li><span class=\"Apple-converted-space\"><strong>lac Y</strong>- encodes for&nbsp;<strong>lactose permease</strong>&nbsp;which increases the permeability of lactose into the cells</span></li>\n<li><span class=\"Apple-converted-space\"><strong>lac A</strong>- encodes for&nbsp;</span><strong>thiogalactoside transacetylase<span class=\"Apple-converted-space\">&nbsp;</span></strong></li>\n</ol>\n<p><span class=\"Apple-converted-space\">The image below shows the genetic arrangement of the lac operon and the process of regulation of lactose metabolism</span></p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/31a9b9443c50419a85ca60ae91fdab11x1279x746.JPEG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC4147",
      "difficulty": "easy"
    },
    {
      "text": "You are a junior researcher studying about the properties of apoproteins.  Which of the following is the basis for the intestine-specific expression of apolipoprotein B-48?",
      "choices": [
        {
          "id": 1,
          "text": "DNA rearrangement and loss"
        },
        {
          "id": 2,
          "text": "DNA transposition"
        },
        {
          "id": 3,
          "text": "RNA alternative splicing"
        },
        {
          "id": 4,
          "text": "RNA editing"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The basis for the intestine-specific expression of <strong>apolipoprotein B-48</strong> is <strong>RNA editing.</strong></p>\n<p>The production of apolipoprotein <strong>(apo) B-48</strong> in the <strong>intestine</strong> and <strong>apoB-100</strong> in the <strong>liver</strong> is a result of <strong>RNA editing. </strong><span>The </span><strong>ApoB gene</strong><span> is </span><strong>transcribed </strong><span>into an</span><strong> mRNA</strong><span> that leads to the synthesis of </span><strong>100 kDa</strong><span> </span><strong>protein </strong><span>in the liver, which is called </span><strong>apoB100</strong><span>. </span><span>In the<strong> intestine</strong>, the same primary transcript is formed, but a<strong> cytidine deaminase</strong> converts a <strong>CAA codon</strong> in the mRNA <strong>into</strong> a <strong>UAA codon;</strong> thus codon for <strong>glutamine</strong> is <strong>changed</strong> to a <strong>termination codon</strong>. Thus<strong> 48kDa protein</strong> has resulted; this is <strong>apoB48.</strong></span></p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/4c3f9ca8abff4817950434dc4cafc5dbx720x558.JPEG\" alt=\"Explanation Image\"><p>DNA rearrangement, transposition and alternate splicing, do alter gene expression but are not the basis of apoB-48 tissue-specific production.</p><hr><h3>Related Pearl: Distribution of  Various Apolipoproteins on Lipoproteins</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Lipoprotein</strong></p>\n</td>\n<td>\n<p><strong>Apolipoprotein</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Chylomicrons</p>\n</td>\n<td>\n<p>A-I, A-II, A-IV, B-48, C-I, C-II, C-III, E</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Chylomicrons remnants</p>\n</td>\n<td>\n<p>B-48, E</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>VLDL</p>\n</td>\n<td>\n<p>B-100, C-I, C-II, C-III, E</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>IDL</p>\n</td>\n<td>\n<p>B-100, E</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>LDL</p>\n</td>\n<td>\n<p>B-100</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>HDL</p>\n</td>\n<td>\n<p>A-I, A-II, A-IV, C-I, C-II, C-III, D, E</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Pre- &beta;- HDL</p>\n</td>\n<td>\n<p>A-I</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p><hr><h3>Related Pearl: Lipoprotein: Types, Sources and Action</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Lipoproteins</strong></p>\n</td>\n<td>\n<p><strong>Source</strong></p>\n</td>\n<td>\n<p><strong>Action</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Chylomicrons</p>\n</td>\n<td>\n<p>Derived from intestinal absorption of triacylglycerol and other lipids</p>\n</td>\n<td>\n<p>Carry exogenous/dietary triacylglycerol from the intestine to peripheral organs</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Very low density lipoproteins (VLDL)</p>\n</td>\n<td>\n<p>Derived from the liver</p>\n</td>\n<td>\n<p>Carry endogenous triacylglycerol from the liver to peripheral organs</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Low-density lipoproteins (LDL)</p>\n</td>\n<td>\n<p>Derived from VLDL</p>\n</td>\n<td>\n<p>Involved in cholesterol transport</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Highdensity lipoproteins (HDL)</p>\n</td>\n<td>\n<p>Derived from Liver, intestine, VLDL, chylomicrons</p>\n</td>\n<td>\n<p>Involved in reverse cholesterol &amp; Phospholipids transport and also in VLDL and chylomicron metabolism</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Intermediate density lipoproteins(IDL)</p>\n</td>\n<td>\n<p>VLDL</p>\n</td>\n<td>\n<p>Triacylglycerol &amp; cholesterol transport</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC0011",
      "difficulty": "medium"
    },
    {
      "text": "A 60-year-old man suffered from acute chest pain, sweating, lightheadedness, and nausea 1 day back. Laboratory reports revealed raised cardiac troponin. ECG was suggestive of myocardial infarction. Which of the following isoenzymes of lactate dehydrogenase (LDH) is likely to be raised?",
      "choices": [
        {
          "id": 1,
          "text": "LDH 3"
        },
        {
          "id": 2,
          "text": "LDH 4"
        },
        {
          "id": 3,
          "text": "LDH 2"
        },
        {
          "id": 4,
          "text": "LDH 1"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p class=\"p1\">This patient had an episode of <strong>myocardial infarction</strong> one day back. Therefore, <strong>LDH-1</strong> is likely to be raised in this case of myocardial infarction.</p>\n<div class=\"page\" title=\"Page 321\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Normally <strong>LDH-2 (H3M1)</strong> concentration in blood is<strong> greater</strong> than <strong>LDH-1 (H4)</strong>, but this pattern is <strong>reversed in myocardial infarction</strong>; this is called the <strong>flipped pattern.</strong></p>\n<div class=\"page\" title=\"Page 321\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>LDH enzyme is a tetramer with 4 subunits. But the subunit may be either H (heart) or M (muscle) polypeptide chains.</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Name of Iso-enzyme</strong></td>\n<td><strong>Subunit makeup of iso-enzyme</strong></td>\n<td><strong>Tissue from which iso-enzyme has originated</strong></td>\n</tr>\n<tr>\n<td>LDH 1</td>\n<td>H4</td>\n<td>Heart muscle</td>\n</tr>\n<tr>\n<td>LDH 2</td>\n<td>H3M1</td>\n<td>RBC</td>\n</tr>\n<tr>\n<td>LDH 3</td>\n<td>H2M2</td>\n<td>Brain</td>\n</tr>\n<tr>\n<td>LDH 4</td>\n<td>H1M3</td>\n<td>Liver</td>\n</tr>\n<tr>\n<td>LDH 5</td>\n<td>M4</td>\n<td>Small intestine</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<div class=\"page\" title=\"Page 321\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>An <strong>increase</strong> in total <strong>LDH level</strong> is seen in<strong> hemolytic anemias</strong>, <strong>hepatocellular damage</strong>, muscular dystrophy, carcinomas, leukemias, and any condition which causes <strong>necrosis of body cells</strong>. Since total LDH is increased in many conditions, the <strong>study of iso-enzymes of LDH </strong>is of <strong>great importance.</strong></p>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div><hr><h3>Related Pearl: Principal Serum Enzymes Used in Clinical Diagnosis</h3><table>\n<tbody>\n<tr>\n<td>&nbsp;<strong>Serum Enzyme</strong></td>\n<td><strong>Major Diagnostic Use/Location</strong></td>\n</tr>\n<tr>\n<td colspan=\"2\">Aminotransferases&nbsp;</td>\n</tr>\n<tr>\n<td>Aspartate aminotransferase (AST/SGOT)</td>\n<td>Liver function</td>\n</tr>\n<tr>\n<td>Alanine aminotransferase (ALT/SGPT)</td>\n<td>Viral hepatitis</td>\n</tr>\n<tr>\n<td colspan=\"2\">Creatine kinase</td>\n</tr>\n<tr>\n<td>CK-MM</td>\n<td>Skeletal muscle,&nbsp;Muscle disorders</td>\n</tr>\n<tr>\n<td>CK-BB</td>\n<td>Brain,&nbsp;Brain injury, meningitis, abnormal cell growth, severe shock, stroke, hypothermia, or restricted blood flow to the bowel.</td>\n</tr>\n<tr>\n<td>CK-MB</td>\n<td>Heart and skeletal muscle, Myocardial Infarction, Muscular dystrophy</td>\n</tr>\n<tr>\n<td colspan=\"2\">Lactate dehydrogenase (LDH)</td>\n</tr>\n<tr>\n<td>HHHH (I<sub>1</sub>)/LDH-1</td>\n<td>Heart &amp; RBC;Myocardial infarction</td>\n</tr>\n<tr>\n<td>HHHM(I<sub>2</sub>)/LDH-2</td>\n<td>Reticuloendothelial system</td>\n</tr>\n<tr>\n<td>HHMM(I<sub>3</sub>)/LDH-3</td>\n<td>Lungs</td>\n</tr>\n<tr>\n<td>HMMM(I<sub>4</sub>)/LDH-4</td>\n<td>Liver &amp; Skeletal Muscles</td>\n</tr>\n<tr>\n<td>MMMM(I<sub>5</sub>)/LDH-5</td>\n<td>Liver &amp; Skeletal Muscles; Liver diseases</td>\n</tr>\n<tr>\n<td colspan=\"2\">Others</td>\n</tr>\n<tr>\n<td>Amylase, Lipase and Acid Phosphatase</td>\n<td>Acute pancreatitis</td>\n</tr>\n<tr>\n<td>Ceruloplasmin</td>\n<td>Hepatolenticular degeneration (Wilson disease)</td>\n</tr>\n<tr>\n<td>&gamma;-Glutamyl transferase</td>\n<td>Liver diseases (Alcoholic Liver Disease)</td>\n</tr>\n<tr>\n<td>&beta;-Glucocerebrosidase</td>\n<td>Gaucher disease</td>\n</tr>\n<tr>\n<td>Alkaline Phosphatase (isozymes)</td>\n<td>Bone disorders, obstructive liver diseases</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF6371",
      "difficulty": "medium"
    },
    {
      "text": "The semi-essential amino acid  is ______",
      "choices": [
        {
          "id": 1,
          "text": "Methionine"
        },
        {
          "id": 2,
          "text": "Tryptophan"
        },
        {
          "id": 3,
          "text": "Leucine"
        },
        {
          "id": 4,
          "text": "Histidine"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Histidine&nbsp;</strong>is a <strong>semi-essential amino acid</strong>.</p>\n<p><strong>Essential </strong>or<strong> indispensable amino acids</strong> are those that cannot be synthesized by the body and need to be supplied through diet. <strong>Semi-essential amino acids</strong> are those that are synthesized adequately by adults but synthesized at rates<strong> inadequate to support growth in children.&nbsp;</strong></p>\n<table>\n<tbody>\n<tr>\n<td>\n<p><strong>Essential Amino Acids</strong></p>\n</td>\n<td>\n<p><strong>Semi-Essential Amino Acids</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<ol>\n<li>Isoleucine</li>\n<li>Leucine</li>\n<li>Lysine</li>\n<li>Methionine</li>\n<li>Phenylalanine</li>\n<li>Threonine</li>\n<li>Tryptophan</li>\n<li>Valine</li>\n</ol>\n</td>\n<td>\n<ol>\n<li>Arginine</li>\n<li><strong>Histidine</strong></li>\n</ol>\n<p>&nbsp;</p>\n<p>&nbsp;</p>\n<p>&nbsp;</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD3987",
      "difficulty": "easy"
    },
    {
      "text": "You are conducting a study on bactericidal activity of immune cells. You find that defects in the metabolism of a particular amino acid lead to dysfunction of nitric oxide production. Identify the involved amino acid.",
      "choices": [
        {
          "id": 1,
          "text": "Serine"
        },
        {
          "id": 2,
          "text": "Alanine"
        },
        {
          "id": 3,
          "text": "Arginine"
        },
        {
          "id": 4,
          "text": "Glutamine"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The involved amino acid is <strong>arginine</strong>, which is required for the production of<strong>&nbsp;nitric oxide (NO)</strong>.</p>\n<p><strong>NO&nbsp;</strong>is an inflammatory mediator synthesized from<strong> arginine</strong> by a calcium-dependent reaction catalyzed by <strong>NO synthase.</strong></p>\n<p>The given image shows the process of nitric oxide synthesis.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/d4d296afd572416f9035ec3f67645237x435x243.PNG\" alt=\"Explanation Image\"><p><strong>The co-enzymes </strong>of NO synthase are :</p>\n<ul>\n<li><strong>FMN</strong></li>\n<li><strong>FAD</strong></li>\n<li><strong>Heme</strong></li>\n<li><strong>Tetrahydrobiopterin (BH4)</strong></li>\n</ul>\n<p><strong>Three isoenzymes</strong> of NO synthase:</p>\n<ul>\n<li><strong>eNOS</strong> (endothelial nitric oxide synthase): Found in the endothelium and plays a role in vasodilatation. It is calcium-calmodulin dependent.</li>\n<li><strong>nNOS</strong> (neural nitric oxide synthase): Found in the neural tissue and acts as a neurotransmitter.&nbsp;It is calcium-calmodulin dependent.</li>\n<li><strong>iNOS</strong> (inducible nitric oxide synthase): TNF-&alpha;, IFN-&gamma; and bacterial endotoxins induce&nbsp;hepatocytes, macrophages, monocytes, and neutrophils to produce this enzyme. It is inducible and calcium independent.</li>\n</ul>\n<p>Functions of NO:</p>\n<div class=\"page\" title=\"Page 150\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<ul>\n<li><strong>Vasodilator</strong>: NO activates the cytosolic form of guanylate cyclase. This increases cGMP, activates protein kinase G, inactivates myosin light-chain kinase and thereby produces<strong>&nbsp;smooth muscle relaxation.</strong></li>\n<li><strong>Macrophage bactericidal activity</strong>: Production of NO synthase is stimulated by bacterial lipopolysaccharide and&nbsp;IFN-&gamma; released in response to infection. The NO formed combines with superoxide radicals from macrophages to form the&nbsp;<strong>OH radical</strong>&nbsp;which is highly bactericidal.&nbsp;</li>\n<li><strong>Inhibitor of platelet aggre&shy;gation</strong>&nbsp;(by activating the cGMP pathway)</li>\n<li><strong>Neurotransmitter</strong>&nbsp;in the brain.</li>\n</ul>\n</div>\n</div>\n</div><hr><h3>Related Pearl: Amino Acid Derivatives</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/7b53b3afcc1c47e792f684ad0097deeex1280x1310.JPEG\" alt=\"Pearl Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA7259",
      "difficulty": "easy"
    },
    {
      "text": "A 20-year-old female patient is referred to a dermatologist for evaluation of vesicles and bullae and increased pigmentation over sun-exposed areas such as the dorsal aspect of the hands and forearms, legs and feet, neck, and face. On further evaluation, she is diagnosed with variegate porphyria. Deficiency of which of the following enzymes causes this disease?",
      "choices": [
        {
          "id": 1,
          "text": "Protoporphyrinogen oxidase"
        },
        {
          "id": 2,
          "text": "Uroporphyrinogen I synthase"
        },
        {
          "id": 3,
          "text": "ALA synthase 2"
        },
        {
          "id": 4,
          "text": "ALA dehydratase"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The cause of variegate porphyria is the&nbsp;<strong>deficiency</strong> of the enzyme <strong>protoporphyrinogen</strong> <strong>oxidase</strong>.</p>\n<p>Variegate porphyria is an <strong>autosomal dominant</strong> disorder caused by a mutation in the <em><strong>PPOX</strong></em> gene, which results in either the deficiency or decreased function of the enzyme <strong>protoporphyrinogen oxidase</strong>. <span><strong>Protoporphyrinogen IX </strong>and other intermediates prior to the block <strong>accumulate</strong> in the <strong>urine.</strong> </span><span>Patients are <strong>photosensitive.</strong></span></p>\n<p>Option B:&nbsp;<strong>Uroporphyrinogen I synthase </strong>deficiency is seen in <strong>acute intermittent porphyria.</strong></p>\n<p>Option C:&nbsp;<strong>ALA synthase 2&nbsp;</strong>deficiency is seen in&nbsp;<strong>X-linked dominant protoporphyria.</strong></p>\n<p>Option D:&nbsp;<strong>ALA dehydratase deficiency</strong> is seen in<strong> amino levulinic acid dehydratase&nbsp;porphyria.</strong></p><hr><h3>Related Pearl: Types of porphyria</h3><p>Clinically porphyrias can be classified into:</p>\n<ul>\n<li>Hepatic porphyria: The overproduction of heme pathway intermediates occurs primarily in the liver.</li>\n<li>Erythropoietic porphyria: The overproduction of heme pathway intermediates occurs primarily in bone marrow erythroid cells.</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/2370f6a3e9e64db5b0d342d7fc4a410fx1280x1964.JPEG\" alt=\"Pearl Image\"><table>\n<tbody>\n<tr>\n<td>\n<div><span><strong>Porphyria type</strong></span></div>\n</td>\n<td>\n<div><span><strong>Deficient </strong> <strong>enzyme</strong></span></div>\n</td>\n<td>\n<div><span><strong>Lab findings</strong></span></div>\n</td>\n<td> </td>\n<td>\n<div><span><strong>Symptoms</strong></span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span>X-linked dominant protoporphyria</span></div>\n<div><span>(XLDPP)</span></div>\n</td>\n<td>\n<div><span>δ-aminolevulinate synthase 2</span></div>\n<div><span>(ALAS - 2)</span></div>\n</td>\n<td><span>Decreased RBC count and hemoglobin</span></td>\n<td>\n<div><span>Cutaneous photosensitivity</span></div>\n</td>\n<td>\n<div><span>Photosensitivity</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span>Aminolevulinate dehydratase deficiency porphyria</span></div>\n<div><span>(ALADP)</span></div>\n</td>\n<td>\n<div><span>δ-aminolevulinate dehydratase</span></div>\n<div><span>(ALAD)</span></div>\n</td>\n<td><span>Increased urinary ALA and coproporphyrin III </span></td>\n<td><span>Neurovisceral symptoms</span></td>\n<td>\n<div><span>Abdominal pain, neuropathy</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span>Acute intermittent porphyria</span></div>\n<div><span>(AIP)</span></div>\n</td>\n<td>\n<div><span>Hydroxymethylbilane synthase</span></div>\n<div><span>(Uroporphyrin I synthase)</span></div>\n</td>\n<td><span>Increased urinary ALA and PBG </span></td>\n<td><span>Neurovisceral symptoms </span></td>\n<td>\n<div><span>Periodic abdominal pain, peripheral neuropathy, psychiatric symptoms, tachycardia</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span>Congenital Erythropoietic porphyria</span></div>\n<div><span>(CEP)</span></div>\n</td>\n<td>\n<div><span>Uroporphyrinogen III synthase</span></div>\n<div><span>(UROS)</span></div>\n</td>\n<td><span>Increased urinary, fecal and red cell uroporphyrin I</span></td>\n<td><span>Cutaneous photosensitivity</span></td>\n<td>\n<div><span>Severe photosensitivity with erythema, swelling and blistering, hemolytic anemia, splenomegaly</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span>Porphyria cutanea tarda (PCT)</span></div>\n</td>\n<td>\n<div><span>Uroporphyrinogen decarboxylase</span></div>\n<div><span>(UROD)</span></div>\n</td>\n<td><span>Increased uroporphyrin I</span></td>\n<td><span> </span>\n<div><span>Cutaneous photosensitivity</span></div>\n</td>\n<td>\n<div><span>Photosensitivity with vesicles and bullae</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span>Hereditary coproporphyria</span></div>\n<div><span>(HCP)</span></div>\n</td>\n<td>\n<div><span>Coproporphyrinogen oxidase</span></div>\n<div><span>(CPOX)</span></div>\n</td>\n<td><span>Increased urinary ALA, PBG, and coproporphyrin III and fecal coproporphyrin III</span></td>\n<td><span>Both</span></td>\n<td>\n<div><span>Photosensitivity, neurologic symptoms, abdominal colic</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span>Variegate porphyria</span></div>\n<div><span>(VP)</span></div>\n</td>\n<td>\n<div><span>Protoporphyrinogen oxidase</span></div>\n<div><span>(PPOX)</span></div>\n</td>\n<td><span>Increased urinary ALA, PBG, and coproporphyrin III and fecal protoporphyrin IX</span></td>\n<td><span>Both</span></td>\n<td>\n<div><span>Photosensitivity, neurologic symptoms, developmental delay</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span>Erythropoietic protoporphyria</span></div>\n<div><span>(EPP)</span></div>\n</td>\n<td>\n<div><span>Ferrochelatase</span></div>\n<div><span>(FECH)</span></div>\n</td>\n<td><span>Increased fecal and red cell protoporphyrin IX </span></td>\n<td><span>Cutaneous photosensitivity</span></td>\n<td>\n<div><span>Non-blistering Photosensitivity with skin lesions</span></div>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<div><span> </span></div>\n<div><span>Most porphyrias are <strong>autosomal dominant</strong> <strong>except:</strong></span></div>\n<div>\n<ul>\n<li><span>ALAD enzyme deficiency porphyria</span></li>\n<li><span>Congenital erythropoietic porphyria</span></li>\n<li><span>Erythropoietic protoporphyria</span></li>\n<li><span>X-linked protoporphyria</span></li>\n</ul>\n</div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF3255",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following enzymes does not belong to class 5 of enzyme classification as per the IUBMB system of classification (International Union of Biochemistry and Molecular Biology)?",
      "choices": [
        {
          "id": 1,
          "text": "Mutase"
        },
        {
          "id": 2,
          "text": "Carbamoyl phosphate synthetase"
        },
        {
          "id": 3,
          "text": "Phosphohexoisomerase"
        },
        {
          "id": 4,
          "text": "Racemase"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Carbamoyl phosphate synthetase</strong> is a ligase -<strong> class 6.</strong></p>\n<p><strong>Class 5 enzymes </strong>are<strong> isomerases.</strong></p><hr><h3>Related Pearl: Enzyme classification</h3><p>There are seven groups of enzymes according to IUBMB.</p>\n<table>\n<tbody>\n<tr>\n<td>E.C. NO.</td>\n<td>Enzyme class</td>\n<td>Type of reaction catalyzed with examples</td>\n</tr>\n<tr>\n<td>1</td>\n<td><strong>O</strong>xidoreductases</td>\n<td>\n<p>Catalyze redox reactions</p>\n<ul>\n<li>Dehydrogenase</li>\n<li>Oxygenase</li>\n<li>Oxidase</li>\n<li>Catalase</li>\n<li>Peroxidase</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>2</td>\n<td><strong>T</strong>ransferases</td>\n<td>\n<p>Catalyze the transfer of functional groups from one substrate to another.</p>\n<ul>\n<li>Kinases</li>\n<li>Transaminases</li>\n<li>Transmethylases</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>3</td>\n<td><strong>H</strong>ydrolases</td>\n<td>\n<p>Catalyze hydrolytic cleavage of C-C, C-O, C-N, and other covalent bonds.</p>\n<ul>\n<li>Lipase</li>\n<li>Arginase</li>\n<li>Pepsin</li>\n<li>Esterase</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>4</td>\n<td><strong>L</strong>yases</td>\n<td>\n<p>Catalyze the cleavage of C-C, C-O, C-N, and other covalent bonds by atom elimination, thereby generating double bonds.</p>\n<ul>\n<li>Aldolase</li>\n<li>Fumarase</li>\n<li>HMG-CoA lyase</li>\n<li>Arginosuccinase</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>5</td>\n<td><strong>I</strong>somerases</td>\n<td>\n<p>Catalyze structural changes within a molecule.</p>\n<ul>\n<li>Phosphohexoisomerase</li>\n<li>Mutase</li>\n<li>Racemase</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>6</td>\n<td><strong>L</strong>igases</td>\n<td>\n<p>Catalyze the joining together of two molecules in reactions.</p>\n<ul>\n<li>Acetyl CoA carboxylase</li>\n<li>PRPP synthetase</li>\n<li>Carbamoyl phosphate synthetase</li>\n<li>Glutamine synthetase</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>7</td>\n<td><strong>T</strong>ranslocases</td>\n<td>Catalyze the movement of molecules or ions across membranes.</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5873",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following statements regarding chaperone proteins is not true?",
      "choices": [
        {
          "id": 1,
          "text": "They are also known as heat shock proteins"
        },
        {
          "id": 2,
          "text": "Most of them are associated with the ATPase enzyme"
        },
        {
          "id": 3,
          "text": "Some bind to hydrophilic parts of proteins to prevent early folding"
        },
        {
          "id": 4,
          "text": "Chaperonins form a barrel structure for unfolded proteins"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The statement 'some bind to hydrophilic parts of proteins to prevent early folding' - is not true.</p>\n<p><strong>Chaperone proteins</strong> actually <strong>bind to</strong> the <strong>hydrophobic parts</strong> of an <strong>unfolded protein</strong> to <strong>prevent early folding</strong>.</p>\n<p>Chaperone proteins, <strong>also known as heat shock proteins,</strong>&nbsp;are special types of proteins that <strong>assist in protein folding</strong> in a few ways. One way is by<strong> binding to</strong> the <strong>hydrophobic parts</strong> of the <strong>elongating polypeptide chain</strong> and <strong>preventing</strong> them from <strong>folding until</strong> the process of protein <strong>synthesis is complete </strong>(e.g. Hsp 70). Another way is by&nbsp;<strong>chaperonin proteins, </strong>another type of chaperone protein, which forms a <strong>cage/barrel-like structure</strong>&nbsp;for unfolded proteins to get sequestered, providing time and suitable conditions to fold properly.<strong>&nbsp;</strong>(e.g. mitochondrial Hsp 60).</p>\n<p>Most chaperone proteins are <strong>associated with</strong> an <strong>ATPase enzyme</strong>. This is because <strong>ATP hydrolysis</strong> is <strong>used</strong> extensively <strong>during</strong> the <strong>process of protein folding</strong>.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF3250",
      "difficulty": "medium"
    },
    {
      "text": "A biochemist is studying the process of reconversion of alanine formed in the muscles, back to glucose inside the liver. Which of the following is false regarding this cycle?",
      "choices": [
        {
          "id": 1,
          "text": "Allows the transport of ammonia"
        },
        {
          "id": 2,
          "text": "Active in fed state"
        },
        {
          "id": 3,
          "text": "Enzyme involved is alanine transaminase"
        },
        {
          "id": 4,
          "text": "Also known as Cahill cycle"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The above cycle described is<strong>&nbsp;</strong>the <strong>glucose-alanine</strong> <strong>cycle</strong> or&nbsp;<strong>Cahill cycle</strong> and it is <strong>not active</strong> in <strong>fed state</strong>.</p>\n<p>In the <strong>fasting state</strong>, muscle glycogen undergoes glycolysis. Pyruvate released during this glycolysis is transaminated to produce alanine. <strong>Alanine</strong> is then <strong>exported</strong> to the <strong>liver</strong>, where it undergoes transamination again back to pyruvate by&nbsp;<strong>alanine transaminase</strong> and enters gluconeogenesis to produce glucose.&nbsp;</p>\n<p>Also, this alanine serves as a <strong>transporter</strong> of <strong>ammonia.</strong>&nbsp;After reaching the liver the alanine is converted into pyruvate and glutamate by transaminase. The glutamate enters the urea cycle carrying the ammonia.</p><hr><h3>Related Pearl: Transport of ammonia in blood (Cahill and Cori cycle)</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/aab20ad1ba7a4eeea5138dd6d3455e08x1280x1597.JPEG\" alt=\"Pearl Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF6753",
      "difficulty": "easy"
    },
    {
      "text": "Match the following glycosaminoglycans (GAGs) with their location.<div class='question-desc-html'><table>\n<tbody>\n<tr>\n<td><strong>GAGs</strong></td>\n<td><strong>Location</strong></td>\n</tr>\n<tr>\n<td>1.&nbsp;Hyaluronic acid</td>\n<td>A. Cornea</td>\n</tr>\n<tr>\n<td>2.&nbsp;Keratan sulfate</td>\n<td>B. Synovial fluid</td>\n</tr>\n<tr>\n<td>3.&nbsp;Heparan sulfate</td>\n<td>C. Mast cell</td>\n</tr>\n<tr>\n<td>4.&nbsp;Heparin</td>\n<td>D. Kidney</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div></div>",
      "choices": [
        {
          "id": 1,
          "text": "1-D, 2-C, 3-B, 4-A"
        },
        {
          "id": 2,
          "text": "1-B, 2-A, 3-D, 4-C"
        },
        {
          "id": 3,
          "text": "1-A, 2-D, 3-C, 4-B"
        },
        {
          "id": 4,
          "text": "1-C, 2-B, 3-A, 4-D"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The option showing<strong>&nbsp;1-B, 2-A, 3-D, 4-C</strong> is correctly matched.</p>\n<table>\n<tbody>\n<tr>\n<td><strong>GAGs</strong></td>\n<td><strong>Location</strong></td>\n</tr>\n<tr>\n<td>1.&nbsp;Hyaluronic acid</td>\n<td>B. Synovial fluid</td>\n</tr>\n<tr>\n<td>2.&nbsp;Keratan sulfate</td>\n<td>A. Cornea</td>\n</tr>\n<tr>\n<td>3.&nbsp;Heparan sulfate</td>\n<td>D. Kidney</td>\n</tr>\n<tr>\n<td>4.&nbsp;Heparin</td>\n<td>C. Mast cell</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>Glycosaminoglycans or mucopolysaccharides are complex carbohydrates made up of&nbsp;<strong>amino sugars and uronic acids</strong>. They may be attached to a protein molecule to form a proteoglycan. Proteoglycans are components of the ground substance of connective tissue. Proteoglycans have a&nbsp;bottle brush appearance<strong>.</strong></p>\n<p><strong>Hyaluronic acid</strong> is the GAG present in <strong>synovial fluid</strong>. It is also found in skin, bone, cartilage, vitreous humor, and embryonic tissues. It contains repeating units of&nbsp;<strong>N Acetyl Glucosamine and Glucuronic acid</strong>. It plays a role in morphogenesis and wound repair. The high concentrations of hyaluronic acid along with <strong>chondroitin sulfates</strong> in <strong>cartilage</strong> contribute to its <strong>compressibility</strong>.</p>\n<p><strong>Keratan sulfate I and II</strong> are the GAGs in the <strong>cornea(KSI), cartilage, and loose connective tissue</strong>. It is the only GAG that does not contain any uronic acid. The repeating units are <strong>galactose and N-acetyl glucosamine</strong> in beta linkage.</p>\n<p><strong>Heparan Sulfate</strong>&nbsp;is found on many extracellular cell surfaces and contains GlcN with fewer N-sulfates than heparin. The predominant uronic acid is <strong>d-glucuronic acid&nbsp;</strong>Heparan sulfates are associated with the plasma membrane of cells where they act as receptors and may participate in the mediation of <strong>cell growth</strong> and <strong>cell-cell communication</strong>. It is also found in the <strong>basement membrane of the kidney</strong> along with type IV collagen and laminin, where it determines the charge selectiveness of glomerular filtration</p>\n<p><strong>Heparin</strong>&nbsp;is found in the granules of <strong>mast cells</strong> and also in the liver, lung, and skin and is an important anticoagulant. It is released into the blood from capillary walls by the action of lipoprotein lipase and it binds with factors IX and XI, but its most important interaction is with plasma antithrombin</p><hr><h3>Related Pearl: Biologically important Glycosoaminoglycans(GAG's)</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>GAG</strong></p>\n</td>\n<td>\n<p><strong>Disaccharide repeat units</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Keratan sulfate</p>\n</td>\n<td>\n<p>N Acetyl Glucosamine + Galactose</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hyaluronic acid</p>\n</td>\n<td>\n<p>N Acetyl Glucosamine + Glucuronic acid</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Chondroitin sulfate</p>\n</td>\n<td>\n<p>N Acetyl Galactosamine + Glucuronic acid</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Dermatan Sulfate</p>\n</td>\n<td>\n<p>N Acetyl Galactosamine + Iduronic/ Glucuronic acid</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Heparan sulfate</p>\n</td>\n<td>\n<p>N Acetyl(Fewer N-sulphated than Heparin)Glucosamine&nbsp;+ Glucuronic acid</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Heparin</p>\n</td>\n<td>\n<p>N Sulphated Glucosamine + Iduronic acid</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF1046",
      "difficulty": "easy"
    },
    {
      "text": "The lab values of a patient reveal a total cholesterol level of  300 mg/dl, TG - 150 mg/dl and HDL - 25 mg/dl . What would be the LDL value?",
      "choices": [
        {
          "id": 1,
          "text": "125"
        },
        {
          "id": 2,
          "text": "245"
        },
        {
          "id": 3,
          "text": "55"
        },
        {
          "id": 4,
          "text": "35"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The LDL value in the above scenario will be <strong>245</strong> mg/dl.</p>\n<p>According to <strong>Friedewald&rsquo;s equation </strong></p>\n<p><strong>LDL-C = TC - HDL-C - (TG/5)&nbsp;</strong></p>\n<p>Where</p>\n<ul>\n<li>HDL-C: High-density lipoprotein cholesterol</li>\n<li>LDL-C: Low-density lipoprotein cholesterol</li>\n<li>TG: Triglycerides</li>\n<li>TC: Total cholesterol</li>\n</ul>\n<p>Substituting the values:</p>\n<p>LDL-C = 300 - 25 - (150/5) = 300-55 = <strong>245 mg/dl</strong></p>\n<p><strong>Note: </strong></p>\n<p><strong>VLDL-C</strong>(Very low-density lipoprotein cholesterol)<strong> = TG/5</strong></p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC6255",
      "difficulty": "hard"
    },
    {
      "text": "After a diet rich in cholesterol, it is seen that the de novo synthesis of cholesterol in the liver decreases. Which of the following enzymes is involved in this?",
      "choices": [
        {
          "id": 1,
          "text": "Acetoacetyl CoA synthase"
        },
        {
          "id": 2,
          "text": "HMG CoA lyase"
        },
        {
          "id": 3,
          "text": "HMG CoA synthase"
        },
        {
          "id": 4,
          "text": "HMG CoA reductase"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>Among the given options, the enzyme&nbsp;<strong>HMG CoA reductase</strong> is involved in the <strong>regulation </strong>of<strong> cholesterol synthesis</strong> in the body.</p>\n<div class=\"page\" title=\"Page 261\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>HMG-CoA</strong> is <strong>reduced</strong> to mevalonate by <strong>NADPH</strong> in a reaction catalyzed by <strong>HMG-CoA reductase</strong> which is the <strong>principal regulatory step</strong> in the pathway of cholesterol synthesis. It is the site of action of the cholesterol-lowering statins, which are HMG-CoA reductase inhibitors.</p>\n</div>\n</div>\n</div>\n</div>\n<p><strong>Long-term regulation</strong> of cholesterol synthesis involves <strong>regulating</strong> the <strong>transcription</strong> of the gene for HMG CoA reductase. When there is <strong>sufficient cholesterol</strong> in the cell, <strong>transcription</strong> of the gene for HMG CoA reductase is <strong>suppressed</strong>, and there is <strong>decreased synthesis</strong> of cholesterol.&nbsp;</p>\n<p>When cholesterol is less, proteases in the Golgi bodies cleave a sterol regulatory element-binding protein (SREBP). The protein which is then formed binds to a sterol regulatory element (SRE) on the DNA. This activates transcription of the HMG CoA reductase gene which increases cholesterol synthesis.</p>\n<p>Hormones that influence HMG reductase are:</p>\n<ul>\n<li><strong>Insulin </strong>and<strong> thyroxine</strong> <strong>increase</strong> the activity of HMG CoA reductase</li>\n<li><strong>Cortisol </strong>and<strong> glucagon decrease</strong> the activity of HMG CoA reductase</li>\n<li><strong>Statins inhibit</strong> the activity of HMG CoA reductase</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/affadf70f6e14d269ed81f681a304e06x600x566.JPEG\" alt=\"Explanation Image\"><p>Other options:</p>\n<p>Option A:<strong> </strong><span><strong>Acetoacetyl CoA synthase</strong> </span><span>catalyzes the reaction that combines two molecules of acetyl-CoA condense forming</span><strong> acetoacetyl-CoA</strong><span>.</span><span class=\"Apple-converted-space\">&nbsp;This acetoacetyl-CoA enters the cholesterol synthesis pathway along with a molecule of acetyl-CoA.</span></p>\n<p>Option B:&nbsp;<strong>HMG CoA lyase</strong> is involved in<strong> ketone body synthesis</strong> which converts HMG coA to acetoacetate.&nbsp;</p>\n<p>Option C: <strong>HMG CoA synthase</strong> catalyzes the reaction where the third molecule of acetyl CoA condenses with acetoacetyl CoA forming<strong> beta-hydroxy beta-methyl glutaryl CoA </strong>(<strong>HMG CoA</strong>).<strong>&nbsp;</strong></p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/7087eb4a999a413da1c7e7c4a3566407x510x692.PNG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF0722",
      "difficulty": "medium"
    },
    {
      "text": "A woman with type 1 diabetes mellitus presents to the emergency room with severe nausea, vomiting, and abdominal pain.  She has a fruity odor of breath and is hyperglycemic.  Urine Rothera's test is positive. Which of the following tissues cannot utilize the non-carbohydrate metabolic byproduct increased in this condition?",
      "choices": [
        {
          "id": 1,
          "text": "Renal cortex"
        },
        {
          "id": 2,
          "text": "Skeletal muscle"
        },
        {
          "id": 3,
          "text": "Liver"
        },
        {
          "id": 4,
          "text": "Cardiac muscle"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The given clinical vignette with a <strong>positive Rothera's test</strong> is suggestive of <strong>diabetic ketoacidosis</strong>. The non-carbohydrate metabolic byproduct increased here is <strong>ketone bodies</strong> and the <strong>liver</strong> <strong>cannot utilize </strong>ketone bodies.</p>\n<p>Type I diabetes mellitus is a <strong>low insulin state</strong>. There is an <strong>increased </strong>conversion of <strong>fatty acids </strong>to <strong>acetyl-CoA</strong> which in turn leads to <strong>increased ketone body</strong> production. The presence of ketosis can be established by the detection of ketone bodies in urine by<strong> Rothera's test</strong>.</p>\n<p>The ketone bodies synthesized in the liver mitochondria are transported in the blood to the peripheral tissues, where they are utilized by the following steps:</p>\n<ul>\n<li>β-hydroxybutyrate is oxidized to acetoacetate by <strong>β-hydroxybutyrate dehydrogenase</strong> producing NADH.</li>\n<li>Acetoacetate is then activated to acetoacetyl CoA by transferring a CoA molecule from succinyl CoA by <strong>succinyl CoA-acetoacetate CoA transferase (thiophorase).</strong></li>\n<li>Acetoacetyl CoA is cleaved into two acetyl CoA molecules by <strong>thiolase</strong> and oxidized into CO<sub>2</sub> by the TCA cycle.</li>\n</ul>\n<p>Ketone bodies are <strong>utilized</strong> by <strong>extrahepatic tissue</strong> like the <strong>cardiac muscle</strong> and <strong>renal cortex</strong> (prefer the ketone bodies to glucose as fuel). Tissues like <strong>skeletal muscle</strong> and the brain can also utilize the ketone bodies as alternate sources of energy if glucose is not available.</p>\n<p><strong>RBCs cannot</strong> utilize ketone bodies as they <strong>lack mitochondria</strong>. The <strong>liver</strong> cannot utilize ketone bodies as it <strong>lacks the enzyme thiophorase.</strong></p><p><strong>Rothera's test:</strong></p>\n<ul>\n<li>Saturate 5 mL of urine with solid ammonium sulfate.</li>\n<li>Add 3 drops of freshly prepared sodium nitroprusside</li>\n<li>Add 2 mL of liquor ammonia along the sides of the test tube.</li>\n</ul>\n<p>Development of a <strong>purple ring</strong> at the junction of the two liquids (shown in the image below) indicates the presence of acetone or acetoacetic acid in urine. It is not answered by beta hydroxy butyrate. </p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/d0a9b8cd80694d72a4b505f199b0eeb4x720x540.JPEG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Ketone body utilisation</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/c4f64f2c484149b98ae69f977b81491ax600x597.JPEG\" alt=\"Pearl Image\"><p>1.&nbsp;3-Hydroxybutyrate dehydrogenase</p>\n<p>2.&nbsp;CoA Transferase</p>\n<p>3.&nbsp;Thiolase</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "ME9561",
      "difficulty": "medium"
    },
    {
      "text": "Match the type of hyperlipoproteinemias in column A with the underlying defects present in column B. (LDL-low-density lipoprotein, VLDL- very low density lipoprotein)<div class='question-desc-html'><table>\n<tbody>\n<tr>\n<td>Column A</td>\n<td>Column B</td>\n</tr>\n<tr>\n<td>1. Type I</td>\n<td>a.&nbsp;Defective LDL receptors</td>\n</tr>\n<tr>\n<td>2. Type IIa</td>\n<td>b. Overproduction of VLDL</td>\n</tr>\n<tr>\n<td>3. Type III</td>\n<td>c. Hepatic lipase deficiency</td>\n</tr>\n<tr>\n<td>4. Type IV</td>\n<td>d. Defective apo E</td>\n</tr>\n<tr>\n<td>&nbsp;</td>\n<td>e. Lipoprotein lipase or Apo C-II deficiency</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div></div>",
      "choices": [
        {
          "id": 1,
          "text": "1-e, 2-a, 3-d, 4-b"
        },
        {
          "id": 2,
          "text": "1-b, 2-a, 3-d, 4-c"
        },
        {
          "id": 3,
          "text": "1-c, 2-b, 3-a, 4-e"
        },
        {
          "id": 4,
          "text": "1-d, 2-b, 3-c, 4-a"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The correct match is&nbsp;<strong>1-e, 2-a, 3-d, 4-b.&nbsp;</strong></p>\n<table>\n<tbody>\n<tr>\n<td>Column A</td>\n<td>Column B</td>\n</tr>\n<tr>\n<td>1. Type I</td>\n<td>e. Lipoprotein lipase or Apo C-II deficiency</td>\n</tr>\n<tr>\n<td>2. Type IIa</td>\n<td>a.&nbsp;Defective LDL receptors</td>\n</tr>\n<tr>\n<td>3. Type III</td>\n<td>d. Defective apo E</td>\n</tr>\n<tr>\n<td>4. Type IV</td>\n<td>b. Overproduction of VLDL</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<table>\n<tbody>\n<tr>\n<td colspan=\"3\"><strong>Dyslipoproteinemias</strong>&nbsp;&nbsp;</td>\n</tr>\n<tr>\n<td colspan=\"3\"><strong>Hypolipoproteinemias&nbsp;</strong></td>\n</tr>\n<tr>\n<td><strong>Name</strong></td>\n<td><strong>Defect</strong></td>\n<td>\n<p class=\"p1\"><strong>Features</strong></p>\n</td>\n</tr>\n<tr>\n<td><strong>Abeta</strong>lipoproteinemia</td>\n<td><strong>Defective loading</strong> of <strong>apo B</strong> with lipid</td>\n<td>\n<p class=\"p1\">No chylomicrons, VLDL, or LDL formation</p>\n<p class=\"p1\"><span class=\"Apple-converted-space\">Intestinal Malabsorption</span></p>\n<p class=\"p1\"><span class=\"Apple-converted-space\">Treated by administration of large doses of vitamin E.&nbsp;</span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p class=\"p2\">Familial &alpha;-lipoprotein deficiency<span class=\"Apple-converted-space\">&nbsp;</span></p>\n<p class=\"p2\">Tangier disease<span class=\"Apple-converted-space\">&nbsp;</span></p>\n<p class=\"p2\">Fish-eye disease<span class=\"Apple-converted-space\">&nbsp;</span></p>\n<p class=\"p3\">Apo A-I deficiencies<span class=\"Apple-converted-space\">&nbsp;</span></p>\n</td>\n<td>Low or near absent HDL is seen in all&nbsp;</td>\n<td>\n<p>Hypertriacylglycerolemia</p>\n<p><span class=\"Apple-converted-space\">Low LDL</span></p>\n<p><span class=\"Apple-converted-space\">Atherosclerosis</span></p>\n</td>\n</tr>\n<tr>\n<td colspan=\"3\"><strong>Hyperlipoproteinemias</strong></td>\n</tr>\n<tr>\n<td>\n<p class=\"p1\">Familial lipoprotein lipase deficiency (<strong>type I)</strong><span class=\"Apple-converted-space\">&nbsp;</span></p>\n</td>\n<td>Defect in <strong>lipoprotein lipase</strong> or apo <strong>C-II</strong></td>\n<td>\n<p>Increased chylomicrons and VLDL</p>\n<p>Low LDL and HDL</p>\n<p>No increased risk of coronary artery disease</p>\n</td>\n</tr>\n<tr>\n<td>\n<p class=\"p1\">Familial hypercholesterolemia (<strong>type IIa</strong>)<span class=\"Apple-converted-space\">&nbsp;</span></p>\n</td>\n<td>Defective <strong>LDL receptors</strong></td>\n<td>\n<p class=\"p1\">Elevated LDL levels and hypercholesterolemia, resulting in atherosclerosis and coronary disease</p>\n</td>\n</tr>\n<tr>\n<td>\n<p class=\"p1\">Familial <strong>type III</strong> hyperlipoproteinemia (broad &beta;-disease, remnant removal disease, familial dysbetalipoproteinemia</p>\n</td>\n<td>Defective <strong>apo E</strong></td>\n<td>\n<p>Increased chylomicrons and VLDL remnants.</p>\n<p class=\"p1\">Hypercholesterolemia, xanthomas, and atherosclerosis are seen</p>\n</td>\n</tr>\n<tr>\n<td>\n<p class=\"p1\">Familial hypertriacylglycerolemia (<strong>type IV</strong>)</p>\n</td>\n<td><strong>Overproduction</strong> of <strong>VLDL</strong></td>\n<td>\n<p>Increased VLDL and cholesterol levels</p>\n<p class=\"p1\">Commonly associated with coronary heart disease, type 2 diabetes mellitus, obesity, alcoholism, and administration of progestational hormones.<span class=\"Apple-converted-space\">&nbsp;</span></p>\n</td>\n</tr>\n<tr>\n<td>Hepatic lipase deficiency</td>\n<td>\n<p class=\"p1\">Accumulation of large triacylglycerol-rich HDL and VLDL remnants.<span class=\"Apple-converted-space\">&nbsp;</span></p>\n</td>\n<td>Xanthomas and coronary artery disease</td>\n</tr>\n<tr>\n<td>\n<p class=\"p1\">Familial hyperalphalipoproteinemia<span class=\"Apple-converted-space\">&nbsp;</span></p>\n</td>\n<td>&nbsp;Increased HDL</td>\n<td>Beneficial condition, but rare&nbsp;</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Familial Dyslipidemias</h3><table>\n<tbody>\n<tr>\n<td>Type</td>\n<td>Increased levels&nbsp;</td>\n<td>Manifestation</td>\n</tr>\n<tr>\n<td>1. Hyperchylomicronemia(type I hyperlipoproteinemia)</td>\n<td>Chylomicrons, VLDL, TG&nbsp;</td>\n<td>Pancreatitis, hepatosplenomegaly, and xanthomas</td>\n</tr>\n<tr>\n<td>2.&nbsp;Familial hypercholesterolemia(type II&nbsp;hyperlipoproteinemia)</td>\n<td>LDL and cholesterol</td>\n<td>Atherosclerosis and xanthomas</td>\n</tr>\n<tr>\n<td>3. Dysbetalipoproteinemia(type III hyperlipoproteinemia)</td>\n<td>Chylomicrons and VLDL</td>\n<td>Atherosclerosis and xanthomas</td>\n</tr>\n<tr>\n<td>4. Hypertriglyceridemia(type IV hyperlipoproteinemia)</td>\n<td>VLDL and TG</td>\n<td>Pancreatitis</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Lipoprotein: Types, Sources and Action</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Lipoproteins</strong></p>\n</td>\n<td>\n<p><strong>Source</strong></p>\n</td>\n<td>\n<p><strong>Action</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Chylomicrons</p>\n</td>\n<td>\n<p>Derived from intestinal absorption of triacylglycerol and other lipids</p>\n</td>\n<td>\n<p>Carry exogenous/dietary triacylglycerol from the intestine to peripheral organs</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Very low density lipoproteins (VLDL)</p>\n</td>\n<td>\n<p>Derived from the liver</p>\n</td>\n<td>\n<p>Carry endogenous triacylglycerol from the liver to peripheral organs</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Low-density lipoproteins (LDL)</p>\n</td>\n<td>\n<p>Derived from VLDL</p>\n</td>\n<td>\n<p>Involved in cholesterol transport</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Highdensity lipoproteins (HDL)</p>\n</td>\n<td>\n<p>Derived from Liver, intestine, VLDL, chylomicrons</p>\n</td>\n<td>\n<p>Involved in reverse cholesterol &amp; Phospholipids transport and also in VLDL and chylomicron metabolism</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Intermediate density lipoproteins(IDL)</p>\n</td>\n<td>\n<p>VLDL</p>\n</td>\n<td>\n<p>Triacylglycerol &amp; cholesterol transport</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Distribution of  Various Apolipoproteins on Lipoproteins</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Lipoprotein</strong></p>\n</td>\n<td>\n<p><strong>Apolipoprotein</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Chylomicrons</p>\n</td>\n<td>\n<p>A-I, A-II, A-IV, B-48, C-I, C-II, C-III, E</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Chylomicrons remnants</p>\n</td>\n<td>\n<p>B-48, E</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>VLDL</p>\n</td>\n<td>\n<p>B-100, C-I, C-II, C-III, E</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>IDL</p>\n</td>\n<td>\n<p>B-100, E</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>LDL</p>\n</td>\n<td>\n<p>B-100</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>HDL</p>\n</td>\n<td>\n<p>A-I, A-II, A-IV, C-I, C-II, C-III, D, E</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Pre- &beta;- HDL</p>\n</td>\n<td>\n<p>A-I</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF0332",
      "difficulty": "easy"
    },
    {
      "text": "A male patient presented with headache and blurry vision. Fundoscopy showed bilateral papilledema. MRI of the brain was normal and showed no space-occupying lesions. On further questioning, he admits to taking high-dose multivitamin supplements. Which vitamin excess is likely to cause the above scenario?",
      "choices": [
        {
          "id": 1,
          "text": "Vitamin D"
        },
        {
          "id": 2,
          "text": "Vitamin K"
        },
        {
          "id": 3,
          "text": "Vitamin E"
        },
        {
          "id": 4,
          "text": "Vitamin A"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<div class=\"ng-scope\">\n<div class=\"ng-scope\">\n<p>The clinical scenario of increased intracranial pressure in the absence of space-occupying lesions points towards the diagnosis of <strong>pseudotumor cerebri</strong>. <strong>Vitamin A excess</strong> is the likely cause.</p>\n<p>Toxicity occurs when the accumulation of vitamin A goes beyond the capacity of intracellular binding proteins. The <strong>unbound vitamin A</strong> causes <strong>membrane lysis</strong> and<strong> tissue damage</strong>.</p>\n</div>\n</div><hr><h3>Related Pearl: Hypervitaminosis A</h3><p><strong>Hypervitaminosis A:</strong></p>\n<ul>\n<li>Vitamin A excess can present as two forms: <strong>vitamin A toxicity</strong> and <strong>carotenaemia</strong>.</li>\n<li>&nbsp;Hypervitaminosis A results from overconsumption of <strong>non‐prescription nutritional supplements</strong>, prescription medications containing vitamin A derivatives and foods high in vitamin A.</li>\n<li>Carotenaemia is a <strong>benign disorder</strong> caused by <strong>excessive &beta;‐carotene</strong>&nbsp;intake.</li>\n<li>In <strong>carotenaemia</strong>, carotenes are excreted from sebaceous glands and sweat glands, and ultimately deposit in the stratum corneum. This results in carotenoderma.</li>\n<li><strong>Acute vitamin A toxicity</strong> manifests with headaches, vision changes, fatigue, anorexia, nausea, vomiting, myalgias and arthralgias. Weight loss can be observed with chronic intoxication.</li>\n<li>Individuals with <strong>chronic hypervitaminosis A</strong> have <strong>dry and scaly skin</strong>, desquamation, cheilitis, alopecia, follicular hyperkeratosis and hyperpigmentation, associated&nbsp;<strong>pseudotumor cerebri</strong> and <strong>skeletal changes</strong> (premature closure of the epiphyses and <strong>pathological bone fractures</strong>).</li>\n<li>Prognosis:\n<ul>\n<li>Vitamin A toxicity: discontinuation of vitamin A leads to resolution of <strong>almost all symptoms</strong> of vitamin A toxicity, with the <strong>exception of cirrhosis</strong> and sequelae related to <strong>pseudotumour cerebri</strong>.</li>\n<li><strong>Carotenaemia:</strong>&nbsp;<strong>Excellent prognosis</strong> with no clear long‐term adverse effects. Pigmentary changes <strong>resolve within weeks to months</strong> of decreasing &beta;‐carotene intake.</li>\n</ul>\n</li>\n</ul>\n<p>&nbsp;</p><hr><h3>Related Pearl: Vitamin-A supplementation & treatment of Vitamin-A deficiency</h3><table>\n<tbody>\n<tr>\n<td colspan=\"3\">\n<div><strong>Vitamin A supplementation</strong></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><strong>Target group</strong></div>\n</td>\n<td>\n<div>6 to 11 months age</div>\n</td>\n<td>\n<div>12 to 59 month of age (1yr to 5yr)</div>\n</td>\n</tr>\n<tr>\n<td>\n<div><strong>Dose</strong></div>\n</td>\n<td>\n<div>100,000 IU (oral)</div>\n</td>\n<td>\n<div>200,000 IU (oral)</div>\n</td>\n</tr>\n<tr>\n<td>\n<div><strong>Frequency</strong></div>\n</td>\n<td>\n<div>Once</div>\n</td>\n<td>\n<div>Every 4&ndash;6 months</div>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>\n<p><strong>Note</strong>: A total dose of&nbsp;<strong>17 lakh IU</strong> given as per the following schedule:</p>\n<ul>\n<li>100,000 IU is given with measles vaccine at 9 months</li>\n<li>200,000 IU is given with DPT booster at 15&ndash;18 months</li>\n<li>200,000 IU is given every 6 months (till 5years of age)</li>\n</ul>\n<p>&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td colspan=\"4\"><strong>Treatment </strong>of vitamin A<strong> deficiency</strong></td>\n</tr>\n<tr>\n<td><strong>Age</strong></td>\n<td>&lt; 6 months</td>\n<td>6-12 months</td>\n<td>&gt; 1 year</td>\n</tr>\n<tr>\n<td><strong>Dose</strong></td>\n<td>50,000 IU</td>\n<td>100,000 IU</td>\n<td>200,000 IU</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>\n<p><strong>Note:</strong> Route of administration is <strong>oral</strong>, in the form of retinyl palmitate.</p><hr><h3>Related Pearl: Fat-soluble vitamins</h3><table>\n<tbody>\n<tr>\n<td rowspan=\"2\"><strong>Vitamin</strong></td>\n<td rowspan=\"2\"><strong>Active form</strong></td>\n<td rowspan=\"2\"><strong>Deficiency</strong></td>\n<td rowspan=\"2\"><strong>Toxicity</strong></td>\n<td colspan=\"3\"><strong>Required dietary allowance</strong></td>\n</tr>\n<tr>\n<td>Children</td>\n<td>Male</td>\n<td>Female</td>\n</tr>\n<tr>\n<td>Vitamin A</td>\n<td>\n<p>Retinol</p>\n<p>Retinal</p>\n<p>Retinoic acid</p>\n</td>\n<td>\n<p>Night blindness, xerophthalmia,</p>\n<p>Acne, psoriasis,</p>\n<p>Impaired immunity</p>\n</td>\n<td>\n<p>Affects lysosomes</p>\n<p>Acute- pseudotumor cerebrii, exfoliative dermatitis</p>\n<p>Chronic-fractures</p>\n</td>\n<td>\n<p>390-630mcg (1-9 years)</p>\n<p>770-1000mcg (10-18 years)</p>\n</td>\n<td>1000mcg&nbsp;</td>\n<td>&nbsp;\n<p>Adult - 840mcg</p>\n<p>Pregnancy - 900mcg</p>\n<p>Lactation - 950 mcg</p>\n</td>\n</tr>\n<tr>\n<td>Vitamin D</td>\n<td>1,25-Dihydro-cholecalciferol</td>\n<td>\n<p>Children- Rickets</p>\n<p>Adults-osteomalacia</p>\n</td>\n<td>Calcinosis</td>\n<td>&nbsp;\n<p>400 IU (&lt;1 year)</p>\n<p>600 IU (&gt;1 year)</p>\n</td>\n<td>&nbsp;600 IU</td>\n<td>\n<p>Adult - 600 IU</p>\n<p>Pregnancy - 600 IU</p>\n<p>Lactation - 600 IU</p>\n</td>\n</tr>\n<tr>\n<td>Vitamin E</td>\n<td>&alpha;-tocopherol</td>\n<td>\n<p>Hemolytic anemia,</p>\n<p>axonal degeneration,</p>\n<p>spinocerebellar ataxia</p>\n</td>\n<td>\n<p>Reduced platelet aggregation,&nbsp;</p>\n<p>Interferes with vitamin K</p>\n</td>\n<td>&nbsp;5-8 mg</td>\n<td>&nbsp;10 mg</td>\n<td>\n<p>Adult - 8 mg</p>\n<p>Pregnancy - 10 mg</p>\n<p>Lactation - 12 mg</p>\n</td>\n</tr>\n<tr>\n<td>Vitamin K</td>\n<td>\n<p>Menedione</p>\n<p>Menoquinone</p>\n<p>Phyloquinone</p>\n</td>\n<td>\n<p>Elevated prothrombin time and bleeding</p>\n<p>Haemorrhagic disease of newborn</p>\n</td>\n<td>\n<p>Hemolysis</p>\n<p>Hyperbilirubinemia</p>\n<p>Kernicterus</p>\n</td>\n<td>\n<p>&lt;1 year - 2-3&nbsp;&micro;g</p>\n<p>Children - 30-50&nbsp;&micro;g</p>\n&nbsp;</td>\n<td>55 &micro;g&nbsp;</td>\n<td>55 &micro;g&nbsp;</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>Note:The <strong>RDA</strong> for <strong>Vitamin D</strong> in the <strong>elderly</strong> (&gt;60 years) is <strong>800 IU</strong>.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA1604",
      "difficulty": "easy"
    },
    {
      "text": "All of the following antioxidants primarily function by reducing the rate of chain initiation, except _______.",
      "choices": [
        {
          "id": 1,
          "text": "Selenium"
        },
        {
          "id": 2,
          "text": "Superoxide dismutase"
        },
        {
          "id": 3,
          "text": "Catalase"
        },
        {
          "id": 4,
          "text": "Glutathione peroxidase"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Superoxide dismutase</strong> acts in the <strong>aqueous phase</strong> to <strong>trap superoxide free radicals</strong>&nbsp;and hence is a <strong>chain-breaking antioxidant</strong>.</p>\n<p><strong>Urate, </strong>and<strong> vitamin E</strong> act in the <strong>lipid phase</strong> to trap free radicals and are also considered <strong>chain-breaking</strong> antioxidants.<span class=\"Apple-converted-space\">&nbsp;</span></p>\n<p>Antioxidants fall into two classes:</p>\n<ul>\n<li><strong>Preventive</strong> antioxidants<strong>&nbsp;reduce</strong> the rate of <strong>chain initiation</strong> of lipid peroxidation.</li>\n<li><strong>Chain-breaking</strong> antioxidants<strong>&nbsp;interfere</strong> with the <strong>chain propagation</strong> phase of lipid peroxidation.</li>\n</ul>\n<p class=\"p2\"><strong>Preventive antioxidants</strong>&nbsp;include:</p>\n<ul>\n<li class=\"p2\"><strong>Catalase</strong>&nbsp;</li>\n<li class=\"p2\"><strong>Glutathione peroxidase</strong></li>\n<li class=\"p2\"><strong>Selenium -</strong>&nbsp;It is an essential component of glutathione peroxidase and regulates its activity</li>\n<li class=\"p2\">Chelators of metal ions such as ethylenediaminetetraacetate (<strong>EDTA</strong>) and diethylenetriaminepentaacetate (<strong>DTPA</strong>).</li>\n</ul><hr><h3>Related Pearl: Types of Antioxidants</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Preventive Antioxidants</strong></p>\n</td>\n<td>\n<p><strong>Chain-breaking Antioxidants</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<ul>\n<li>Catalase</li>\n<li>Glutathione peroxidase</li>\n<li>Chelator of metal Ions-Ceruloplasmin &amp; Transferrin</li>\n</ul>\n</td>\n<td><br />\n<ul>\n<li>Superoxide dismutase</li>\n<li>Urate</li>\n<li>Vitamin E</li>\n<li>Polyphenols</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF6394",
      "difficulty": "hard"
    },
    {
      "text": "Cardiac edema and neuropathy are seen to be present in a patient with suspected nutritional deficiency.  Which of the following biochemical assays would you advise?",
      "choices": [
        {
          "id": 1,
          "text": "RBC glutathione reductase"
        },
        {
          "id": 2,
          "text": "RBC Trans-ketolase"
        },
        {
          "id": 3,
          "text": "RBC transaminase"
        },
        {
          "id": 4,
          "text": "Glucose-6-phosphate dehydrogenase"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Cardiac edema and neuropathy</strong> are associated with a deficiency of <strong>thiamine (vitamin B1).&nbsp;</strong>Measurement of <strong>erythrocyte</strong>&nbsp;<strong>transketolase&nbsp;</strong>provides an index of&nbsp;<strong>vitamin B1&nbsp;nutritional status</strong>.&nbsp;</p>\n<p><strong>Thiamine diphosphate (Vit B1)</strong>&nbsp;is the&nbsp;<strong>cofactor</strong> of <strong>transketolase</strong> which is <span>involved in the <strong>pentose phosphate pathway</strong></span>, <span><strong>pyruvate dehydrogenase </strong></span><span>which is </span><span>involved </span><span>in <strong>carbohydrate metabolism</strong></span><span>, </span><span><strong>&alpha;-ketoglutarate dehydrogenase</strong> which is involved </span><span>in the <strong>citric acid cycle</strong></span><span>, and </span><strong><span>branched-chain keto acid </span></strong><span><strong>dehydrogenase</strong> which is involved </span><span>in the <strong>metabolism of leucine, isoleucine, and valine.</strong></span></p>\n<p><strong>Wet beriberi (cardiac)</strong> is associated with tachycardia, cardiomegaly, cardiac failure, and edema. It is commonly seen in the&nbsp;<strong>refugee camps</strong>&nbsp;where people consume&nbsp;<strong>polished rice</strong>-based monotonous diets. Diagnosis of thiamine deficiency can be established by&nbsp;<strong>erythrocyte transketolase</strong>&nbsp;activity assessment.</p>\n<p><strong>Dry beriberi</strong> is associated with neurological deficits such as peripheral neuropathy, optic atrophy, ataxia, and irritability. Complications include&nbsp;<strong>lactic acidosis</strong>&nbsp;and Wernicke encephalopathy in adults.</p><hr><h3>Related Pearl: Biochemical Assay for Vitamin Deficiency State</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Vitamin</strong></p>\n</td>\n<td>\n<p><strong>Assay and test</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Vitamin B1 (Thiamine)</p>\n</td>\n<td>\n<p>RBC Trans-ketolase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Vitamin B2 (Riboflavin)</p>\n</td>\n<td>\n<p>RBC glutathione reductase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Vitamin B6 (Pyridoxine)</p>\n</td>\n<td>\n<p>RBC transaminase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Vitamin B9 (Folic acid)</p>\n</td>\n<td>\n<p>FIGLU excretion/Histidine load test</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Vitamin B12 (Cobalamine)</p>\n</td>\n<td>\n<p>Serum methyl malonate level</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Vitamin Deficiency States (Water-soluble Vitamins)</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Vitamin</strong></p>\n</td>\n<td>\n<p><strong>Deficiency State</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Thiamine (<strong>B<sub>1</sub></strong>)</p>\n</td>\n<td>\n<p><strong>Beriberi</strong></p>\n<p>Wernicke&ndash;Korsakoff&rsquo;s syndrome</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Riboflavin (<strong>B<span>2</span></strong>)</p>\n</td>\n<td>\n<p>Cheilosis, Magenta-coloured tongue,&nbsp;</p>\n<p>Glossitis, Seborrheic dermatitis</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Niacin (<strong>B<span>3</span></strong>)</p>\n</td>\n<td>\n<p><strong>Pellagra</strong></p>\n<p>Dermatitis, Diarrhea, Dementia</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Pantothenic acid (<strong>B<span>5</span></strong>)</p>\n</td>\n<td>\n<p><strong>Burning foot syndrome</strong> (historically called as \"Nutritional melalgia\")</p>\n<div class=\"page\" title=\"Page 90\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Dermatitis, enteritis, alopecia, ataxia</p>\n</div>\n</div>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<p>Pyridoxine (<strong>B<span>6</span></strong>)</p>\n</td>\n<td>\n<p>Microcytic anemia, convulsions, depression</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Biotin (<strong>B<span>7</span></strong>)</p>\n</td>\n<td>\n<p>Relatively unknown</p>\n<p>Dermatitis, atrophic glossitis, alopecia, paraesthesia, muscle pain, anorexia, hallucinations</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Folic acid (<strong>B<span>9</span></strong>)</p>\n</td>\n<td>\n<p>Megaloblastic anemia, neuropathy, neural tube defects, atrophic glossitis</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Cobalamin (<strong>B<span>12</span></strong>)</p>\n</td>\n<td>\n<p>Pernicious anemia, dementia, spinal cord degeneration, homocysteinemia</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Ascorbic acid (<strong>C</strong>)</p>\n</td>\n<td>\n<p><strong>Scurvy</strong></p>\n<p>Ecchymosis, bleeding gums, poor wound healing, fatigue, joint effusion, Scorbutic rosary</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5484",
      "difficulty": "easy"
    },
    {
      "text": "A 12-year-old boy is brought by his parents with complaints of diarrhea and dermatitis. The child had neutral aminoaciduria and a positive Obermeyer test result. Which of the following is the precursor of the vitamin that is deficient in the patient?",
      "choices": [
        {
          "id": 1,
          "text": "Threonine"
        },
        {
          "id": 2,
          "text": "Tyrosine"
        },
        {
          "id": 3,
          "text": "Tryptophan"
        },
        {
          "id": 4,
          "text": "Phenylalanine"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The clinical vignette is suggestive of <strong>p</strong><strong>ellagra&nbsp;</strong>secondary to&nbsp;<strong>Hartnup disease.&nbsp;</strong>The vitamin deficiency in this condition is&nbsp;<strong>niacin.&nbsp;</strong>The precursor of niacin is <strong>tryptophan</strong>.</p>\n<p><strong>Niacin</strong>/vitamin B3 is a constituent of&nbsp;<strong>NAD</strong>&nbsp;and&nbsp;<strong>NADP. </strong>Its&nbsp;deficiency occurs in a maize-based diet (<strong>maize is deficient in tryptophan</strong>), carcinoid syndrome (all the tryptophan is converted to serotonin), and <strong>H</strong><strong>artnup disease</strong> (defective absorption of tryptophan from intestine and kidney).</p>\n<p>Niacin deficiency causes pellagra (3Ds):</p>\n<ol>\n<li>Diarrhea</li>\n<li>Dermatitis (<strong>Casal necklace</strong>)</li>\n<li>Dementia</li>\n</ol>\n<p>The image below shows a <strong>Casal necklace</strong>&mdash;a <strong>ring-like rash</strong> seen <strong>around the neck</strong>&nbsp;caused by the deficiency of niacin.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/eec286b6420c49519fa9c57255710cdex720x521.JPEG\" alt=\"Explanation Image\"><p>Diagnosis of niacin deficiency secondary to Hartnup disease&nbsp;is based on<strong> neutral&nbsp;aminoaciduria</strong>&nbsp;and increased excretion of indole compounds detected by the&nbsp;<strong>Obermeyer test</strong>.</p>\n<div class=\"page\" title=\"Page 499\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Nicotinic acid <strong>inhibits the flux of free fatty acids</strong> from adipose tissue; so the <strong>acetyl CoA </strong>pool is <strong>reduced</strong>; and hence <strong>serum cholesterol is lowered</strong>. In high doses, niacin is useful to r<strong>educe Lp(a) levels.</strong></p>\n</div>\n</div>\n</div>\n</div>\n<p><span>Niacin toxicity - Nicotinic acid when given orally or parenterally produces a<strong> transient vasodilatation of the cutaneous vessels</strong> and<strong> histamine release.</strong> The reaction is accompanied by<strong> itching, burning,</strong> and <strong>tingling.</strong> Intake of nicotinic acid in excess of 50 mg/day may lead to <strong>liver damage.</strong></span></p><hr><h3>Related Pearl: Conditions Associated with Pellagra-like Symptoms</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Condition/Disease</strong></p>\n</td>\n<td>\n<p><strong>Reason for niacin deficiency</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hartnup disease</p>\n</td>\n<td>\n<p>Intestinal &amp; renal malabsorption of tryptophan</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Carcinoid syndrome</p>\n</td>\n<td>\n<p>Overproduction of serotonin that causes diversion of  tryptophan from NAD+ Pathway</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Vitamin B6 deficiency</p>\n</td>\n<td>\n<p>Defective kynureninase pathway</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Maize rich diet</p>\n</td>\n<td>\n<p>Niacin is in unavailable niacytin form</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Jowar diet (Sorghum)</p>\n</td>\n<td>\n<p>Increase leucine content inhibit QPRTase enzyme</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Vitamin Deficiency States (Water-soluble Vitamins)</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Vitamin</strong></p>\n</td>\n<td>\n<p><strong>Deficiency State</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Thiamine (<strong>B<sub>1</sub></strong>)</p>\n</td>\n<td>\n<p><strong>Beriberi</strong></p>\n<p>Wernicke&ndash;Korsakoff&rsquo;s syndrome</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Riboflavin (<strong>B<span>2</span></strong>)</p>\n</td>\n<td>\n<p>Cheilosis, Magenta-coloured tongue,&nbsp;</p>\n<p>Glossitis, Seborrheic dermatitis</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Niacin (<strong>B<span>3</span></strong>)</p>\n</td>\n<td>\n<p><strong>Pellagra</strong></p>\n<p>Dermatitis, Diarrhea, Dementia</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Pantothenic acid (<strong>B<span>5</span></strong>)</p>\n</td>\n<td>\n<p><strong>Burning foot syndrome</strong> (historically called as \"Nutritional melalgia\")</p>\n<div class=\"page\" title=\"Page 90\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Dermatitis, enteritis, alopecia, ataxia</p>\n</div>\n</div>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<p>Pyridoxine (<strong>B<span>6</span></strong>)</p>\n</td>\n<td>\n<p>Microcytic anemia, convulsions, depression</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Biotin (<strong>B<span>7</span></strong>)</p>\n</td>\n<td>\n<p>Relatively unknown</p>\n<p>Dermatitis, atrophic glossitis, alopecia, paraesthesia, muscle pain, anorexia, hallucinations</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Folic acid (<strong>B<span>9</span></strong>)</p>\n</td>\n<td>\n<p>Megaloblastic anemia, neuropathy, neural tube defects, atrophic glossitis</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Cobalamin (<strong>B<span>12</span></strong>)</p>\n</td>\n<td>\n<p>Pernicious anemia, dementia, spinal cord degeneration, homocysteinemia</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Ascorbic acid (<strong>C</strong>)</p>\n</td>\n<td>\n<p><strong>Scurvy</strong></p>\n<p>Ecchymosis, bleeding gums, poor wound healing, fatigue, joint effusion, Scorbutic rosary</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Active Forms and Functions of Water-Soluble Vitamins</h3><table>\n<tbody>\n<tr>\n<td rowspan=\"2\">\n<p>Vitamin</p>\n</td>\n<td colspan=\"2\">\n<p>Coenzyme</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Name</p>\n</td>\n<td>\n<p>Function</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>B1(Thiamin)</p>\n</td>\n<td>\n<p>Thiamine pyrophosphate (TPP)</p>\n</td>\n<td>\n<p>Decarboxylation</p>\n<p>Transketolase reaction</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>B2(Riboflavin)</p>\n</td>\n<td>\n<p>Flavin-adenine-dinucelotide (FAD)</p>\n</td>\n<td>\n<p>Hydrogen Transfer</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>B3(Nicotinic acid, niacin)</p>\n</td>\n<td>\n<p>Nicotinamide-adenine dinucleotide(NAD<sup>+</sup>)</p>\n</td>\n<td>\n<p>Hydrogen Transfer</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>B5(Pantothenic acid)</p>\n</td>\n<td>\n<p>Coenzyme A</p>\n</td>\n<td>\n<p>Transfer of an acyl group</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>B6(Pyridoxine)</p>\n</td>\n<td>\n<p>Pyridoxal Phosphate(PLP)</p>\n</td>\n<td>\n<p>Transamination</p>\n<p>Decarboxylation</p>\n<p>Co-factor of glycogen phosphorylase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>B7(Biotin)</p>\n</td>\n<td>\n<p>Biotin</p>\n</td>\n<td>\n<p>Carboxylation</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>B9(Folic acid)</p>\n</td>\n<td>\n<p>Tetrahydrofolic acid (THFA)</p>\n</td>\n<td>\n<p>Donor of methyl/formyl group</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>B12(Cobalamin)</p>\n</td>\n<td>\n<p>Methylcobalamin and Adenosylcobalamin</p>\n</td>\n<td>\n<p>Co-factor of methionine synthase and methylmalonyl CoA mutase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>C (Ascorbic acid)</p>\n</td>\n<td>Ascorbic acid and dehydroascorbic acid</td>\n<td>\n<p>Oxidation-reduction</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF3819",
      "difficulty": "easy"
    },
    {
      "text": "A 1-year-old male baby presents with a history of fever, irritability, and vomiting. On examination, there is moderate hepatomegaly. Laboratory investigations reveal elevated levels of serum transaminases and elevated levels of succinylacetone in serum and urine. Which enzyme is deficient in this baby?",
      "choices": [
        {
          "id": 1,
          "text": "Fumarylacetoacetate hydroxylase"
        },
        {
          "id": 2,
          "text": "Tyrosine aminotransferase"
        },
        {
          "id": 3,
          "text": "4-hydroxy-phenyl pyruvate dioxygenase"
        },
        {
          "id": 4,
          "text": "Phenylalanine hydroxylase"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><span data-preserver-spaces=\"true\">The clinical scenario and laboratory findings are diagnostic of <strong>t</strong></span><strong><span data-preserver-spaces=\"true\"><strong>yrosinemia</strong> type I</span></strong><span data-preserver-spaces=\"true\">&nbsp;and the enzyme deficient is&nbsp;</span><strong><span data-preserver-spaces=\"true\">fumarylacetoacetate hydroxylase (FAH).</span></strong></p>\n<p><span data-preserver-spaces=\"true\">Tyrosinemia type I or <strong>Hepatorenal tyrosinemia</strong> is caused by FAH deficiency. It is an&nbsp;</span><strong><span data-preserver-spaces=\"true\">autosomal recessive disease</span></strong><span data-preserver-spaces=\"true\">, caused by a defective&nbsp;</span><strong><span data-preserver-spaces=\"true\">FAH gene</span></strong><span data-preserver-spaces=\"true\">. This results in the accumulation of&nbsp;</span><strong><span data-preserver-spaces=\"true\">fumarylacetoacetate</span></strong><span data-preserver-spaces=\"true\">&nbsp;and&nbsp;</span><strong><span data-preserver-spaces=\"true\">succinylacetone</span></strong><span data-preserver-spaces=\"true\">&nbsp;which are metabolites of tyrosine degradation. The tissues most affected are hepatic, renal, and nervous tissues. The manifestations of these can be seen in the form of an&nbsp;</span><strong><span data-preserver-spaces=\"true\">acute hepatic crisis</span></strong><span data-preserver-spaces=\"true\">, such as in this case.&nbsp;They may also present with&nbsp;<strong>peripheral neuropathy</strong>&nbsp;resembling acute porphyria.&nbsp;<strong>Renal involvement</strong>&nbsp;is manifested as a <strong>Fanconi-like syndrome</strong> with hyperphosphaturia, hypophosphatemia, and vitamin D-resistant rickets.<br /></span></p>\n<p><span data-preserver-spaces=\"true\"><strong>Boiled cabbage odor</strong>&nbsp;may be present in classical type 1 tyrosinemia resulting from increased&nbsp;<strong>methionine metabolites</strong>&nbsp;(sulfur-containing compounds). Boiled cabbage odor can also be found in cases of <strong>hypermethioninemia.</strong><br /></span></p>\n<p><span data-preserver-spaces=\"true\">The diagnosis can be established by the demonstration of&nbsp;</span><strong><span data-preserver-spaces=\"true\">elevated levels </span></strong>of<strong><span data-preserver-spaces=\"true\"> succinylacetone</span></strong><span data-preserver-spaces=\"true\">&nbsp;in urine or blood. The treatment of choice is&nbsp;</span><strong><span data-preserver-spaces=\"true\">nitisinone (NTBC)</span></strong><span data-preserver-spaces=\"true\">&nbsp;which reduces the formation of fumarylacetoacetate and succinylacetone by <strong>inhibiting</strong> the <strong>degradation</strong> of <strong>tyrosine</strong>. However, this increases the plasma levels of tyrosine. A&nbsp;</span><strong><span data-preserver-spaces=\"true\">diet low in tyrosine&nbsp;</span></strong><span data-preserver-spaces=\"true\">and phenylalanine is also prescribed to patients.</span></p>\n<p><span data-preserver-spaces=\"true\">Other options:</span></p>\n<p><span data-preserver-spaces=\"true\">Option B:&nbsp;</span><strong><span data-preserver-spaces=\"true\">Tyrosine aminotransferase</span></strong><span data-preserver-spaces=\"true\">&nbsp;is deficient in <strong>t</strong></span><strong><span data-preserver-spaces=\"true\"><strong>yrosinemia</strong> type II</span></strong><span data-preserver-spaces=\"true\">&nbsp;(<strong>Richner-Hanhart syndrome</strong> or <strong>oculocutaneous tyrosinemia</strong>). It is also an <strong>autosomal</strong> <strong>recessive</strong> disease that results in <strong>hyperkeratosis</strong>, herpetiform <strong>corneal ulcers</strong>, and intellectual disability. The laboratory finding here is marked hypertyrosinemia and&nbsp;</span><strong><span data-preserver-spaces=\"true\">elevated 4-hydroxyphenylpyruvic acid</span></strong><span data-preserver-spaces=\"true\">. The treatment here also involves a diet low in tyrosine and phenylalanine.</span></p>\n<p><span data-preserver-spaces=\"true\">Option C:&nbsp;<strong>4-hydroxy-phenyl pyruvate dioxygenase </strong>deficiency&nbsp;causes&nbsp;<strong>type III tyrosinemia</strong>&nbsp;(neonatal tyrosinemia). Patients might rarely have a mental disability. The liver function is generally normal. <strong>Hawkinsinuria</strong> is an autosomal dominant disorder caused due to deficiency of&nbsp;<strong>4-hydroxy-phenyl pyruvate dioxygenase.</strong></span></p>\n<p><span data-preserver-spaces=\"true\">Option D:</span><strong><span data-preserver-spaces=\"true\">&nbsp;Phenylalanine hydroxylase</span></strong><span data-preserver-spaces=\"true\">&nbsp;deficiency causes&nbsp;</span><strong><span data-preserver-spaces=\"true\">phenylketonuria</span></strong><span data-preserver-spaces=\"true\">. It manifests as progressive intellectual disability. The diagnosis is made by measurement of plasma phenylalanine levels or by detecting&nbsp;</span><strong><span data-preserver-spaces=\"true\">phenyl ketones in the urine.</span></strong><span data-preserver-spaces=\"true\">&nbsp;A diet low in phenylalanine is the mainstay of treatment.&nbsp;</span></p>\n<p>The steps and enzymes of tyrosine metabolism are shown below.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/36893c4004af444289964d1b4af63913x1280x2566.JPEG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Amino acid Enzymatic Disorders and the Associated Enzymes</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Disorder</strong></p>\n</td>\n<td>\n<p><strong>Enzyme defect</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Phenylketonuria</p>\n</td>\n<td>\n<p>Phenylalanine hydroxylase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Tyrosinosis (Tyrosinemia type I)</p>\n</td>\n<td>\n<p>Maleyl Acetate isomerase or Fumarylacetoacetate hydrolase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Maple syrup urine disease&nbsp;</p>\n</td>\n<td>\n<p>Branched-chain alpha-keto acid dehydrogenase(BCKAD)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Alkaptonuria</p>\n</td>\n<td>\n<p>Homogentisate oxidase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Albinism</p>\n</td>\n<td>\n<p>Tyrosinase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Homocystinuria type I</p>\n</td>\n<td>\n<p>Cystathionine synthase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Homocystinuria type II</p>\n</td>\n<td>\n<p>Defect in methylcobalamin formation</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Cystathioninuria</p>\n</td>\n<td>\n<p>Cystathionase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Tyrosinemia type II or Richner-Hanhart syndrome</p>\n</td>\n<td>\n<p>Tyrosine transaminase or Tyrosine aminotransferase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Primary hyperoxaluria</p>\n</td>\n<td>\n<p>Alanine glyoxalate aminotransferase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hypervalinemia</p>\n</td>\n<td>\n<p>Valine transaminase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Isovaleric acidemia</p>\n</td>\n<td>\n<p>Isovaleryl CoA dehydrogenase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Histidinemia</p>\n</td>\n<td>\n<p>Histidase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hyperprolinemia type I</p>\n</td>\n<td>\n<p>Proline oxidase</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p><hr><h3>Related Pearl: Types of tyrosinemia  with deficient enzymes</h3><table>\n<tbody>\n<tr>\n<td>\n<div><strong>Disease</strong></div>\n</td>\n<td>\n<div><strong>Enzyme-deficient</strong></div>\n</td>\n</tr>\n<tr>\n<td>\n<div>Tyrosinemia type 1 (Hepatorenal, Hereditary tyrosinemia, Tyrosinosis)</div>\n</td>\n<td>\n<div>Fumarylacetoacetate hydrolase (FAAH)</div>\n</td>\n</tr>\n<tr>\n<td>\n<div>Tyrosinemia type 2 (Oculocutaneous)</div>\n</td>\n<td>\n<div>Tyrosine aminotransferase</div>\n</td>\n</tr>\n<tr>\n<td>\n<div>Tyrosinemia type 3 (Neonatal tyrosinemia)</div>\n</td>\n<td>\n<div>4-Hydroxyphenylpyruvate dioxygenase (4-HPPD)</div>\n</td>\n</tr>\n<tr>\n<td>\n<div>Hawkinsinuria</div>\n</td>\n<td>\n<div>Missense mutations in the gene for 4-HPPD</div>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Inborn Errors of Amino Acid Metabolism and Their Associated Urine Odor</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Inborn Error of Metabolism</strong></p>\n</td>\n<td>\n<p><strong>Urine Odor</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Maple syrup urine disease</p>\n</td>\n<td>\n<p>Maple syrup</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hawkinsinuria</p>\n</td>\n<td>\n<p>Swimming pool</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>3-Hydroxy-3-methylglutaric aciduria</p>\n</td>\n<td>\n<p>Cat urine</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Isovaleric acidemia</p>\n<p>Glutaric acidemia (type II)</p>\n</td>\n<td>\n<p>Sweaty feet</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hypermethioninemia</p>\n<p>Tyrosinemia</p>\n</td>\n<td>\n<p>Boiled cabbage</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Multiple carboxylase deficiency</p>\n</td>\n<td>\n<p>Tomcat urine</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Phenylketonuria</p>\n</td>\n<td>\n<p>Mousy</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Trimethylaminuria</p>\n</td>\n<td>\n<p>Rotting fish</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Oasthouse syndrome</p>\n</td>\n<td>\n<p>Dried malt/hops</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF2033",
      "difficulty": "medium"
    },
    {
      "text": "Identify the type of isomerism shown by the 2 molecules represented in the below image.",
      "choices": [
        {
          "id": 1,
          "text": "Anomers"
        },
        {
          "id": 2,
          "text": "Epimers"
        },
        {
          "id": 3,
          "text": "Diastereomers"
        },
        {
          "id": 4,
          "text": "Functional isomers"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>In the above image, D-glucose and D-mannose differ in the position of &ndash;OH group in the second carbon atom. Hence, they are<strong> epimers.</strong></p>\n<p><strong>Isomers</strong> that <strong>differ</strong> in configuration<strong> around only one specific carbon atom</strong> (with the exception of the carbonyl carbon) are defined as epimers of each other.</p>\n<p>Examples for epimers of glucose:</p>\n<ul>\n<li>Mannose (epimerized at carbon 2)</li>\n<li>Galactose (epimerized at carbon 4)</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/3d11234c8b6e42e9bd3e244015927c3bx255x223.PNG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Aldoses and Ketoses</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Carbohydrate</strong></p>\n</td>\n<td>\n<p><strong>Aldose</strong></p>\n</td>\n<td>\n<p><strong>Ketose</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Triose</p>\n</td>\n<td>\n<p>Glyceraldehyde</p>\n</td>\n<td>\n<p>Dihydroxy Acetone</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Tetroses</p>\n</td>\n<td>\n<p>Erythrose</p>\n</td>\n<td>\n<p>Erythrulose</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Pentoses</p>\n</td>\n<td>\n<p>Ribose,Xylose,Arabinose</p>\n</td>\n<td>\n<p>Ribulose, Xylulose</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hexoses</p>\n</td>\n<td>\n<p>Glucose, Galactose, Mannose</p>\n</td>\n<td>\n<p>Fructose</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Heptoses</p>\n</td>\n<td>\n<p> </p>\n</td>\n<td>\n<p>Sedoheptulose</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/b8e0678132f74f838553415b617226a3.PNG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD3240",
      "difficulty": "easy"
    },
    {
      "text": "A 6-year-old girl is brought with a history of impaired vision. On examination, she has light hair, light skin color, and pale blue iris. The child has a normal IQ.  You suspect a disorder due to a deficiency of an enzyme tyrosinase. What is the diagnosis of this patient?",
      "choices": [
        {
          "id": 1,
          "text": "Albinism"
        },
        {
          "id": 2,
          "text": "Phenylketonuria"
        },
        {
          "id": 3,
          "text": "Alkaptonuria"
        },
        {
          "id": 4,
          "text": "Tyrosinemia type 2"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The clinical features along with the deficiency of the enzyme <strong>tyrosinase</strong> point to the diagnosis of <strong>albinism</strong>.</p>\n<p>The first step in melanin synthesis involves the oxidation of L-tyrosine to DOPA by the enzyme <strong>tyrosinase</strong>. Tyrosinase again acts on DOPA to form dopaquinone, which undergoes a series of reactions to form <strong>melanin</strong>. Mutations in the tyrosinase gene lead to a complete inability to produce melanin.</p>\n<p>Albinism is inherited in an <strong>autosomal recessive</strong> pattern.<strong> Oculocutaneous albinism (OCA)</strong> is characterized by a reduction or complete lack of <strong>melanin</strong> pigment in the skin, hair, and eyes. This manifests as <strong>white hair, white skin</strong>, and <strong>iris</strong> appearing <strong>blue-gray</strong> in oblique light. Ocular manifestations include <strong>photophobia</strong>, nystagmus, and <strong>decreased visual acuity.</strong> The <strong>IQ</strong> of the child will be <strong>normal</strong>.</p>\n<p>Given below is an image of a young child with <strong>albinism</strong> showing white hair, skin, and pale iris:</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/1c9c676c89be4b9c8df90e33a6622eecx794x527.JPEG\" alt=\"Explanation Image\"><p>Other options:</p>\n<p>Option B: <strong>Phenylalanine hydroxylase</strong> deficiency leads to <strong>phenylketonuria</strong>. This defect results in the impaired conversion of <strong>phenylalanine to tyrosine</strong>. Infants appear normal at birth. They gradually develop hyperactivity, agitation, <strong>low IQ</strong>, and <strong>hypopigmentation</strong> (due to tyrosine deficiency), <strong>Phenylacetate</strong> gives rise to the characteristic <strong>mousy odor</strong> in the body sweat, and urine.</p>\n<p>Option C: The metabolic defect in <strong>alkaptonuria</strong> is a defective <strong>homogentisate oxidase</strong>. Patients typically will have <strong>dark urine</strong> or urine that turns dark on standing, <strong>ochronosis</strong>(bluish-black pigmentation in connective tissue), <strong>arthritis</strong>, the pigment in the sclera, and ear cartilage.</p>\n<p>Option D:&nbsp;<strong>Tyrosinemia type 2 </strong>(<strong>oculocutaneous type</strong>)&nbsp;is caused due to the deficiency of the enzyme&nbsp;<strong>tyrosine transaminase.</strong>&nbsp;Clinical findings include palmoplantar <strong>keratosis</strong>, painful corneal erosions with <strong>photophobia</strong>, and&nbsp;<strong>learning disability</strong>.</p><hr><h3>Related Pearl: Amino acid Enzymatic Disorders and the Associated Enzymes</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Disorder</strong></p>\n</td>\n<td>\n<p><strong>Enzyme defect</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Phenylketonuria</p>\n</td>\n<td>\n<p>Phenylalanine hydroxylase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Tyrosinosis (Tyrosinemia type I)</p>\n</td>\n<td>\n<p>Maleyl Acetate isomerase or Fumarylacetoacetate hydrolase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Maple syrup urine disease&nbsp;</p>\n</td>\n<td>\n<p>Branched-chain alpha-keto acid dehydrogenase(BCKAD)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Alkaptonuria</p>\n</td>\n<td>\n<p>Homogentisate oxidase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Albinism</p>\n</td>\n<td>\n<p>Tyrosinase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Homocystinuria type I</p>\n</td>\n<td>\n<p>Cystathionine synthase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Homocystinuria type II</p>\n</td>\n<td>\n<p>Defect in methylcobalamin formation</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Cystathioninuria</p>\n</td>\n<td>\n<p>Cystathionase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Tyrosinemia type II or Richner-Hanhart syndrome</p>\n</td>\n<td>\n<p>Tyrosine transaminase or Tyrosine aminotransferase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Primary hyperoxaluria</p>\n</td>\n<td>\n<p>Alanine glyoxalate aminotransferase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hypervalinemia</p>\n</td>\n<td>\n<p>Valine transaminase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Isovaleric acidemia</p>\n</td>\n<td>\n<p>Isovaleryl CoA dehydrogenase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Histidinemia</p>\n</td>\n<td>\n<p>Histidase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hyperprolinemia type I</p>\n</td>\n<td>\n<p>Proline oxidase</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB9983",
      "difficulty": "easy"
    },
    {
      "text": "A teenage girl comes to your clinic complaining of easy bruising. She gives a history of prolonged intake of antibiotics to treat her acne. Which among the following vitamin deficiencies might have led to her present condition?",
      "choices": [
        {
          "id": 1,
          "text": "Niacin"
        },
        {
          "id": 2,
          "text": "Menaquinone"
        },
        {
          "id": 3,
          "text": "Methylcobalamine"
        },
        {
          "id": 4,
          "text": "Biotin"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>History of <strong>easy bruising</strong> after <strong>prolonged use of antibiotics</strong> is suggestive of <strong>menaquinone/vitamin K deficiency</strong>. Prolonged use of antibiotics leads to vitamin K deficiency. This is due to the loss of normal bowel flora that synthesizes menaquinones (vitamin K2). Menaquinones type of vitamin K is produced by gut bacteria.</p>\n<p>Vitamin K is required for the functioning are the blood-clotting factors <strong>II, VII, IX, X, protein C, and protein S</strong>. Vitamin K deficiency causes easy bruising, bleeding, elevated prothrombin time, and hemorrhagic disease in newborns.</p>\n<p>Vitamin K is a <strong>fat-soluble</strong> vitamin. The following are the vitamers of vitamin K:</p>\n<ul>\n<li aria-level=\"1\"><strong>Phylloquinone</strong> (Vitamin <strong>K1</strong>) is the normal dietary source of Vitamin K that is found in green vegetables.</li>\n<li aria-level=\"1\"><strong>Menaquinone</strong> (Vitamin <strong>K2</strong>) is synthesized by intestinal bacteria.</li>\n<li aria-level=\"1\"><strong>Menadione</strong> (Vitamin <strong>K3</strong>) is a synthetic compound that is metabolized to phylloquinone.</li>\n</ul><hr><h3>Related Pearl: Fat-soluble vitamins</h3><table>\n<tbody>\n<tr>\n<td rowspan=\"2\"><strong>Vitamin</strong></td>\n<td rowspan=\"2\"><strong>Active form</strong></td>\n<td rowspan=\"2\"><strong>Deficiency</strong></td>\n<td rowspan=\"2\"><strong>Toxicity</strong></td>\n<td colspan=\"3\"><strong>Required dietary allowance</strong></td>\n</tr>\n<tr>\n<td>Children</td>\n<td>Male</td>\n<td>Female</td>\n</tr>\n<tr>\n<td>Vitamin A</td>\n<td>\n<p>Retinol</p>\n<p>Retinal</p>\n<p>Retinoic acid</p>\n</td>\n<td>\n<p>Night blindness, xerophthalmia,</p>\n<p>Acne, psoriasis,</p>\n<p>Impaired immunity</p>\n</td>\n<td>\n<p>Affects lysosomes</p>\n<p>Acute- pseudotumor cerebrii, exfoliative dermatitis</p>\n<p>Chronic-fractures</p>\n</td>\n<td>\n<p>390-630mcg (1-9 years)</p>\n<p>770-1000mcg (10-18 years)</p>\n</td>\n<td>1000mcg&nbsp;</td>\n<td>&nbsp;\n<p>Adult - 840mcg</p>\n<p>Pregnancy - 900mcg</p>\n<p>Lactation - 950 mcg</p>\n</td>\n</tr>\n<tr>\n<td>Vitamin D</td>\n<td>1,25-Dihydro-cholecalciferol</td>\n<td>\n<p>Children- Rickets</p>\n<p>Adults-osteomalacia</p>\n</td>\n<td>Calcinosis</td>\n<td>&nbsp;\n<p>400 IU (&lt;1 year)</p>\n<p>600 IU (&gt;1 year)</p>\n</td>\n<td>&nbsp;600 IU</td>\n<td>\n<p>Adult - 600 IU</p>\n<p>Pregnancy - 600 IU</p>\n<p>Lactation - 600 IU</p>\n</td>\n</tr>\n<tr>\n<td>Vitamin E</td>\n<td>&alpha;-tocopherol</td>\n<td>\n<p>Hemolytic anemia,</p>\n<p>axonal degeneration,</p>\n<p>spinocerebellar ataxia</p>\n</td>\n<td>\n<p>Reduced platelet aggregation,&nbsp;</p>\n<p>Interferes with vitamin K</p>\n</td>\n<td>&nbsp;5-8 mg</td>\n<td>&nbsp;10 mg</td>\n<td>\n<p>Adult - 8 mg</p>\n<p>Pregnancy - 10 mg</p>\n<p>Lactation - 12 mg</p>\n</td>\n</tr>\n<tr>\n<td>Vitamin K</td>\n<td>\n<p>Menedione</p>\n<p>Menoquinone</p>\n<p>Phyloquinone</p>\n</td>\n<td>\n<p>Elevated prothrombin time and bleeding</p>\n<p>Haemorrhagic disease of newborn</p>\n</td>\n<td>\n<p>Hemolysis</p>\n<p>Hyperbilirubinemia</p>\n<p>Kernicterus</p>\n</td>\n<td>\n<p>&lt;1 year - 2-3&nbsp;&micro;g</p>\n<p>Children - 30-50&nbsp;&micro;g</p>\n&nbsp;</td>\n<td>55 &micro;g&nbsp;</td>\n<td>55 &micro;g&nbsp;</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>Note:The <strong>RDA</strong> for <strong>Vitamin D</strong> in the <strong>elderly</strong> (&gt;60 years) is <strong>800 IU</strong>.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD0027",
      "difficulty": "medium"
    },
    {
      "text": "A 30-year old woman is on chronic therapy with the anti-TB drug Isoniazid. Which of the following vitamin deficiencies is likely to develop in this individual?",
      "choices": [
        {
          "id": 1,
          "text": "Thiamine"
        },
        {
          "id": 2,
          "text": "Riboflavin"
        },
        {
          "id": 3,
          "text": "Pyridoxine"
        },
        {
          "id": 4,
          "text": "Biotin"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Isoniazid</strong>, a drug used to treat <strong>tuberculosis,</strong> can <strong>induce&nbsp;</strong>a <strong>vitamin B6 deficiency.</strong></p>\n<p><strong>Isoniazid</strong>&nbsp;is the first-line antitubercular drug that inhibits the production of&nbsp;<strong>mycolic acid</strong>. It is a bactericidal drug against tubercle bacilli. Important side effects of isoniazid include&nbsp;<strong>peripheral neuritis</strong>,&nbsp;<strong>hepatitis</strong>, anemia, rashes, and arthralgia.</p>\n<p><strong>Peripheral neuritis</strong>&nbsp;occurs due to interference with the production of active&nbsp;<strong>coenzyme pyridoxal phosphate</strong>&nbsp;from pyridoxine. Patients present with clinical features of&nbsp;<strong>pyridoxine/vitamin B6</strong>&nbsp;deficiency, which include&nbsp;<strong>paresthesias</strong>, numbness, and<strong>&nbsp;tingling sensation</strong>.</p>\n<div class=\"ng-star-inserted\">\n<div class=\"table-responsive font-weight-light answer-scroll ng-star-inserted\">\n<p>The most widely used method to know the<strong>&nbsp;vitamin B6 nutritional status</strong>&nbsp;is by&nbsp;<strong>measuring</strong>&nbsp;the&nbsp;<strong>RBC transaminase activity</strong>, by adding pyridoxal phosphate in vitro. Direct measurement of the plasma concentrations of the vitamin (pyridoxal phosphate) can also be done.</p>\n</div>\n</div>\n<p>Therefore,&nbsp;<strong>10 mg/day&nbsp;of pyridoxine&nbsp;</strong>is given prophylactically along with isoniazid to prevent&nbsp;<strong>neurotoxicity</strong>.</p><hr><h3>Related Pearl: Vitamin Deficiency States (Water-soluble Vitamins)</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Vitamin</strong></p>\n</td>\n<td>\n<p><strong>Deficiency State</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Thiamine (<strong>B<sub>1</sub></strong>)</p>\n</td>\n<td>\n<p><strong>Beriberi</strong></p>\n<p>Wernicke&ndash;Korsakoff&rsquo;s syndrome</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Riboflavin (<strong>B<span>2</span></strong>)</p>\n</td>\n<td>\n<p>Cheilosis, Magenta-coloured tongue,&nbsp;</p>\n<p>Glossitis, Seborrheic dermatitis</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Niacin (<strong>B<span>3</span></strong>)</p>\n</td>\n<td>\n<p><strong>Pellagra</strong></p>\n<p>Dermatitis, Diarrhea, Dementia</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Pantothenic acid (<strong>B<span>5</span></strong>)</p>\n</td>\n<td>\n<p><strong>Burning foot syndrome</strong> (historically called as \"Nutritional melalgia\")</p>\n<div class=\"page\" title=\"Page 90\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Dermatitis, enteritis, alopecia, ataxia</p>\n</div>\n</div>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<p>Pyridoxine (<strong>B<span>6</span></strong>)</p>\n</td>\n<td>\n<p>Microcytic anemia, convulsions, depression</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Biotin (<strong>B<span>7</span></strong>)</p>\n</td>\n<td>\n<p>Relatively unknown</p>\n<p>Dermatitis, atrophic glossitis, alopecia, paraesthesia, muscle pain, anorexia, hallucinations</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Folic acid (<strong>B<span>9</span></strong>)</p>\n</td>\n<td>\n<p>Megaloblastic anemia, neuropathy, neural tube defects, atrophic glossitis</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Cobalamin (<strong>B<span>12</span></strong>)</p>\n</td>\n<td>\n<p>Pernicious anemia, dementia, spinal cord degeneration, homocysteinemia</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Ascorbic acid (<strong>C</strong>)</p>\n</td>\n<td>\n<p><strong>Scurvy</strong></p>\n<p>Ecchymosis, bleeding gums, poor wound healing, fatigue, joint effusion, Scorbutic rosary</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB3269",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following methods are used for the detection of RNA?<div class='question-desc-html'><ol>\n<li>PCR</li>\n<li>Real-time PCR</li>\n<li>RT-PCR</li>\n<li>Northern blotting</li>\n<li>Western blotting</li>\n</ol></div>",
      "choices": [
        {
          "id": 1,
          "text": "1, 3"
        },
        {
          "id": 2,
          "text": "2, 4"
        },
        {
          "id": 3,
          "text": "3, 5"
        },
        {
          "id": 4,
          "text": "3, 4"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The methods that can be used for the<strong> detection </strong>of<strong> RNA </strong>are<strong> northern blotting </strong>and <strong>RT-PCR </strong>(option D - 3, 4).</p>\n<p><strong>PCR</strong> (polymerase chain reaction) is a technique used to amplify a selected DNA sequence. It can be used to synthesize millions of copies of the selected DNA sequence in a few hours, enabling the detection of even trace amounts of DNA in a sample. Therefore, PCR is used for:</p>\n<ul>\n<li>Detecting <strong>mutant DNA&nbsp;</strong></li>\n<li><strong>DNA fingerprinting</strong> for forensic analysis- Detection of DNA from small amounts of samples from the crime scene</li>\n<li>Detection of <strong>latent viral infections</strong></li>\n<li><strong>Carrier detection</strong> of cystic fibrosis</li>\n</ul>\n<p><strong>Real-time PCR</strong> <span>is used for quantitation of the number of viruses present in a sample e.g. viral load in HIV or HBV. So, the treatment modalities can be planned and the response to treatment can be assessed.</span></p>\n<p><strong>RT-PCR</strong> or reverse transcriptase PCR is used for the detection of&nbsp;<strong>RNA.&nbsp;</strong>It can be used to <strong>quantitate mRNA levels</strong>&nbsp;by generating complementary DNA <strong>(cDNA) copies</strong> of the mRNA using the <strong>reverse transcriptase</strong> enzyme.&nbsp;</p>\n<p><strong>The northern blot </strong>technique can also be used to detect <strong>RNAs.</strong>&nbsp;Here, the mixture of <strong>mRNA</strong> molecules is separated by electrophoresis and then transferred to a nitrocellulose membrane and hybridized with radiolabeled probes.<strong><br /></strong></p>\n<p><strong>Western blot,&nbsp;</strong>also called<strong> immunoblots,&nbsp;</strong>is a&nbsp;technique used to study <strong>protein </strong>molecules<strong>.&nbsp;</strong>The proteins undergo electrophoresis and then are transferred to a membrane. These proteins are then tagged with the specific antibodies and visualized.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF6796",
      "difficulty": "easy"
    },
    {
      "text": "A 10-month-old baby is brought to the pediatric department with characteristic hair as shown in the image. Further examination shows that the child has truncal hypotonia, and failure to thrive. Which of the following genetic mutation will be seen in this child?",
      "choices": [
        {
          "id": 1,
          "text": "ATP8B gene on Chromosome 13"
        },
        {
          "id": 2,
          "text": "ATP8A gene on Chromosome X"
        },
        {
          "id": 3,
          "text": "ATP7A gene on Chromosome X"
        },
        {
          "id": 4,
          "text": "ATP7B gene on Chromosome 13"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>In the given clinical scenario, the image showing an irritable child with<strong> kinky colorless, and</strong>&nbsp;<strong>sparse hair with truncal hypotonia</strong> on examination is suggestive of <strong>Menke's disease</strong>. It is due to a defect in the <strong>ATP7A gene on chromosome X.</strong></p>\n<p>Menkes disease is a rare <strong>X-linked recessive</strong> progressive multisystemic disease of copper metabolism.&nbsp;In this<span> condition, dietary copper is absorbed from the GI tract but it <strong>cannot</strong> be <strong>transported</strong> to<strong> blood </strong>due to the <strong>absence of</strong> an intracellular <strong>copper binding ATPase </strong>(mutation in ATP7A gene). Copper deficiency results in the <strong>defective </strong>function of<strong> the lysyl oxidase</strong> enzyme and thus leading to reduced cross-linkage of collagen.</span></p>\n<p>Note :</p>\n<ul>\n<li>ATP7A: Menkes disease - X-linked&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;</li>\n<li>ATP7B: Wilson's disease - Autosomal recessive (Chromosome 13)&nbsp;<strong>(Option D)</strong></li>\n</ul>\n<p>Other options-</p>\n<p>Option (A) and (B) are not associated with disorders of copper absorption.</p><hr><h3>Related Pearl: Menkes disease</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/3f0c58fe358940b393c96afe12ef3455x1280x1951.JPEG\" alt=\"Pearl Image\">",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/dfc65b7efdfb4149ae70e10b49084a24.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF0362",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following amino acids will have the maximum buffering capacity at physiological pH?",
      "choices": [
        {
          "id": 1,
          "text": "Histidine"
        },
        {
          "id": 2,
          "text": "Tyrosine"
        },
        {
          "id": 3,
          "text": "Lysine"
        },
        {
          "id": 4,
          "text": "Cysteine"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Histidine</strong> has the <strong>maximum buffering capacity</strong> at <strong>physiological pH.</strong></p>\n<p>Histidine has a<strong> pKa value of 6.5-7.4 </strong>(due to the imidazole group),<strong>&nbsp;</strong>which is<strong>&nbsp;close&nbsp;to</strong> the <strong>physiological pH</strong> of the blood and is maintained in the range of&nbsp;<strong>7.35 -7.45.</strong></p>\n<p>The <strong>maximum buffering capacity</strong> of an amino acid is when the <strong>pH=pKa</strong>. Therefore,&nbsp;at physiological pH<strong>, </strong>the <strong>buffering action </strong>in the blood is caused by <strong>histidine.&nbsp;</strong></p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD3968",
      "difficulty": "easy"
    },
    {
      "text": "A patient presents with cheilosis, magenta-colored tongue, glossitis, and seborrheic dermatitis. These are manifestations of which of the following vitamin deficiency?",
      "choices": [
        {
          "id": 1,
          "text": "Vitamin B2"
        },
        {
          "id": 2,
          "text": "Vitamin B1"
        },
        {
          "id": 3,
          "text": "Vitamin B7"
        },
        {
          "id": 4,
          "text": "Vitamin B5"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>Cheilosis, magenta-colored tongue, glossitis, and seborrheic dermatitis are manifestations of&nbsp;<strong>vitamin&nbsp;</strong><strong>B2 </strong>(<strong>riboflavin</strong>) deficiency.</p>\n<p><strong>Riboflavin (vitamin B2)</strong></p>\n<p>The active form of riboflavin is Flavin mononucleotide(FMN) and Flavin Adenine Dinucleotide (FAD). <strong>FMN</strong> is present in <strong>Complex I of ETC</strong> and<strong> FAD</strong> is present in<strong> Complex II in ETC.</strong></p>\n<p><strong>FAD-dependent</strong> enzymes</p>\n<ul>\n<li>Succinate dehydrogenase</li>\n<li>Pyruvate dehydrogenase</li>\n<li>Alpha-ketoglutarate dehydrogenase</li>\n<li>Xanthine oxidase</li>\n<li>Acyl CoA dehydrogenase</li>\n</ul>\n<p>Riboflavin is <strong>synthesized</strong> in the body by<strong> intestinal flora</strong>. Dietary sources rich in riboflavin are <strong>liver, dried yeast, egg,</strong> and whole milk. Fish, whole cereals, legumes, and green leafy vegetables are also good sources of riboflavin. <span>Riboflavin is light-sensitive</span><strong>. </strong><span>Hence</span><strong> riboflavin supplementation may be</strong>&nbsp;required during <span>phototherapy for hyperbilirubinemia&nbsp;</span></p>\n<p><strong>Clinical features</strong> of riboflavin deficiency include the <strong>proliferation</strong> of the <strong>bulbar</strong> <strong>conjunctival</strong> capillaries(the <strong>earliest sign</strong> of riboflavin deficiency) angular stomatitis, circumcorneal vascularization, cheilosis, magenta-colored tongue, glossitis, and seborrheic dermatitis.</p><hr><h3>Related Pearl: Vitamin Deficiency States (Water-soluble Vitamins)</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Vitamin</strong></p>\n</td>\n<td>\n<p><strong>Deficiency State</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Thiamine (<strong>B<sub>1</sub></strong>)</p>\n</td>\n<td>\n<p><strong>Beriberi</strong></p>\n<p>Wernicke&ndash;Korsakoff&rsquo;s syndrome</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Riboflavin (<strong>B<span>2</span></strong>)</p>\n</td>\n<td>\n<p>Cheilosis, Magenta-coloured tongue,&nbsp;</p>\n<p>Glossitis, Seborrheic dermatitis</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Niacin (<strong>B<span>3</span></strong>)</p>\n</td>\n<td>\n<p><strong>Pellagra</strong></p>\n<p>Dermatitis, Diarrhea, Dementia</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Pantothenic acid (<strong>B<span>5</span></strong>)</p>\n</td>\n<td>\n<p><strong>Burning foot syndrome</strong> (historically called as \"Nutritional melalgia\")</p>\n<div class=\"page\" title=\"Page 90\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Dermatitis, enteritis, alopecia, ataxia</p>\n</div>\n</div>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<p>Pyridoxine (<strong>B<span>6</span></strong>)</p>\n</td>\n<td>\n<p>Microcytic anemia, convulsions, depression</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Biotin (<strong>B<span>7</span></strong>)</p>\n</td>\n<td>\n<p>Relatively unknown</p>\n<p>Dermatitis, atrophic glossitis, alopecia, paraesthesia, muscle pain, anorexia, hallucinations</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Folic acid (<strong>B<span>9</span></strong>)</p>\n</td>\n<td>\n<p>Megaloblastic anemia, neuropathy, neural tube defects, atrophic glossitis</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Cobalamin (<strong>B<span>12</span></strong>)</p>\n</td>\n<td>\n<p>Pernicious anemia, dementia, spinal cord degeneration, homocysteinemia</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Ascorbic acid (<strong>C</strong>)</p>\n</td>\n<td>\n<p><strong>Scurvy</strong></p>\n<p>Ecchymosis, bleeding gums, poor wound healing, fatigue, joint effusion, Scorbutic rosary</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD4016",
      "difficulty": "easy"
    },
    {
      "text": "An infant was brought to OPD with complaints of copious nasal discharge. On examination, there was a clouding of the cornea and hepatomegaly. The developmental assessment showed significant delay. An x-ray of the chest was taken and is given below. Which of the following enzyme is defective in this child?",
      "choices": [
        {
          "id": 1,
          "text": "Iduronate 2-sulphatase"
        },
        {
          "id": 2,
          "text": "Heparan sulfate-N-sulfatase"
        },
        {
          "id": 3,
          "text": "α-N-Acetylglucosaminidase"
        },
        {
          "id": 4,
          "text": "α-L-Iduronidase"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>In the given clinical scenario presence of corneal clouding with hepatomegaly with developmental delay and the X-ray showing <strong>oar-shaped ribs</strong> is suggestive of <strong>Hurler's syndrome</strong> and the enzyme deficient in this condition is&nbsp;<strong>&alpha;-L-Iduronidase.</strong></p>\n<p><strong>Hurler's syndrome&nbsp;</strong>is a&nbsp;<strong>severe</strong>&nbsp;type of mucopolysaccharidoses&nbsp;<strong>(MPS) - I</strong>. It is caused due to deficiency of&nbsp;<strong>&alpha;-L-iduronidase.&nbsp;</strong>This enzyme is required for the breakdown of <strong>dermatan and heparan sulfate</strong>. The deficiency of the enzyme leads to the accumulation of these mucopolysaccharides.&nbsp;</p>\n<p>Affected children usually present between&nbsp;<strong>6-24 months</strong> of age. Clinical features include <span><strong>hepatosplenomegaly,</strong> coarse facial features, <strong>corneal clouding</strong>, large tongue, enlarged head circumference, joint stiffness, short stature, skeletal dysplasia, </span><span>recurrent upper respiratory tract and ear </span><span>infections, noisy breathing, and <strong>persistent copious nasal discharge. </strong>Children with Hurler's syndrome have <strong>impaired language function</strong> because of <strong>i</strong></span><strong>ntellectual disability</strong> which occurs due to the <strong>accumulation of heparan sulfate </strong>and combined <strong>conductive and sensorineural </strong>hearing loss.</p>\n<p><strong>Skeletal dysplasia,</strong> called dysostosis multiplex includes <strong>oar-shaped ribs(widening of anterior ribs)</strong>, ovoid vertebral bodies, enlarged diaphyses of the long bones, macrocephaly, and enlarged J-shaped sella.</p>\n<p>The image below shows <strong>coarse facial features</strong> and the radiograph shows&nbsp;<strong>enlarged diaphyses</strong>&nbsp;of the metacarpal and phalanges.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/dde6608a05dd498b9e137195c96bf8c7x720x1757.JPEG\" alt=\"Explanation Image\"><p>Other options: &nbsp;</p>\n<p>Option A:&nbsp;<strong>Hunter syndrome</strong>&nbsp;is a&nbsp;<strong>type II MPS.&nbsp;</strong>It occurs due to the deficiency of&nbsp;<strong>iduronate 2-sulfatase.&nbsp;</strong>It shares the same features of type I MPS like coarse facial features, short stature, and dysostosis multiplex. However, there is&nbsp;<strong>no corneal clouding.&nbsp;</strong>It is the only MPS which&nbsp;<strong>X-linked recessive</strong>&nbsp;inheritance. So if a&nbsp;female&nbsp;baby&nbsp;is affected in the family, it is less likely to be Hunter syndrome.&nbsp;</p>\n<p>Option B: <strong>Sanfilippo syndrome A</strong> or <strong>MPS type III-A</strong> occurs due to the deficiency of <strong>heparan sulfate-N-sulfatase enzyme</strong>, leading to the accumulation of heparan sulfate. The affected children usually have delayed milestones and motor dysfunction.</p>\n<p>Option C:&nbsp;<strong>Sanfilippo syndrome B&nbsp;</strong>or&nbsp;<strong>MPS type III-B&nbsp;</strong>occurs due to the deficiency of&nbsp;<strong>&alpha;-N-Acetylglucosaminidase enzyme</strong>,&nbsp;leading to the accumulation of heparan sulfate. The affected children usually have delayed milestones and motor dysfunction.</p><hr><h3>Related Pearl: MPS and Their Respective Enzyme Deficiencies</h3><table>\n<tbody>\n<tr>\n<td><strong>Disease</strong></td>\n<td><strong>MPS</strong></td>\n<td><strong>Enzyme defective</strong></td>\n<td><strong>GAGs affected</strong></td>\n<td><strong>Symptoms</strong></td>\n</tr>\n<tr>\n<td>Hurler-, Scheie-,&nbsp;<br />Hurler-scheie syndrome</td>\n<td>MPS I</td>\n<td>&alpha;-L-Iduronidase</td>\n<td>\n<p>Dermatan sulfate,<br />Heparan sulfate</p>\n</td>\n<td>Mental retardation,<br />coarse facial features,&nbsp;<br />Hepatosplenomegaly<br />Cloudy cornea</td>\n</tr>\n<tr>\n<td>Hunter syndrome</td>\n<td>MPS II</td>\n<td>Iduronate sulfatase</td>\n<td>Dermatan sulfate,&nbsp;<br />Heparan sulfate</td>\n<td>Mental retardation</td>\n</tr>\n<tr>\n<td>Sanfilippo&nbsp;syndrome A</td>\n<td>MPS IIIA</td>\n<td>Heparan sulfate-N-sulfatase</td>\n<td>Heparan sulfate</td>\n<td>Delay in development<br />Motor dysfunction</td>\n</tr>\n<tr>\n<td>Sanfilippo&nbsp;syndrome B</td>\n<td>MPS III B</td>\n<td>&alpha;-N-Acetylglucosaminidase</td>\n<td>Heparan sulfate</td>\n<td>As MPS III A</td>\n</tr>\n<tr>\n<td>Sanfilippo&nbsp;syndrome C</td>\n<td>MPS III C</td>\n<td>&alpha;-glucosaminide N-acetyltransferase</td>\n<td>Heparan sulfate</td>\n<td>As MPS III A &nbsp;</td>\n</tr>\n<tr>\n<td>Sanfilippo&nbsp;syndrome D</td>\n<td>MPS III D</td>\n<td>N-acetylglucosamine 6-sulfatase</td>\n<td>Heparan sulfate</td>\n<td>As MPS III A &nbsp;</td>\n</tr>\n<tr>\n<td>Morquio syndrome A</td>\n<td>MPS IV A</td>\n<td>Galactosamine&nbsp;6-sulfatase</td>\n<td>Keratan sulfate&nbsp;<br />Chondroitin 6-sulfate&nbsp;</td>\n<td>Skeletal dysplasia<br />short stature</td>\n</tr>\n<tr>\n<td>Morquio syndrome B</td>\n<td>MPS IV B</td>\n<td>&beta;-galactosidase</td>\n<td>Keratan sulfate</td>\n<td>As MPS IV A</td>\n</tr>\n<tr>\n<td>Maroteaux-lamy&nbsp;syndrome&nbsp;</td>\n<td>MPS VI</td>\n<td>N-acetylgalactosamine 4-sulfatase</td>\n<td>Dermatan sulfate</td>\n<td>Curvature of the spine,<br />Short stature<br />Skeletal dysplasia<br />Cardiac defects</td>\n</tr>\n<tr>\n<td>Sly&nbsp;syndrome&nbsp;</td>\n<td>MPS VII</td>\n<td>&beta;-glucuronidase</td>\n<td>Dermatan sulfate<br />Heparan sulfate<br />Chondroitin 4-sulfate&nbsp;<br />Chondroitin 6-sulfate&nbsp;<br /><br /></td>\n<td>Short stature<br />Skeletal dysplasia<br />Hepatomegaly<br />Cloudy cornea</td>\n</tr>\n<tr>\n<td>Natowicz&nbsp;syndrome&nbsp;</td>\n<td>MPS IX</td>\n<td>Hyaluronidase</td>\n<td>Hyaluronic acid</td>\n<td>Joint Pain<br />Short stature&nbsp;</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Enzyme Replacement Therapy for Lysosomal Storage Disorders</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>&nbsp;Lysosomal Storage Disorder</strong></p>\n</td>\n<td>\n<p><strong>Enzyme deficient</strong></p>\n</td>\n<td>\n<p><strong>Enzyme Replacement Therapy</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hurler Syndrome (MPS I)</p>\n</td>\n<td>\n<p>&alpha;-L -iduronidase</p>\n</td>\n<td>\n<p>Laronidase (Aldurazyme)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hunter Syndrome (MPS II)</p>\n</td>\n<td>\n<p>Iduronate sulfate sulfatase</p>\n</td>\n<td>\n<p>Idursulfase (Elaprase)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Morquio A Syndrome (MPS IVA)</p>\n</td>\n<td>\n<p>N-Acetylgalactosamine-6-sulfate sulfatase</p>\n</td>\n<td>\n<p>Elosulfase (Vimizim)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Maroteaux&ndash;Lamy Syndrome (MPS VI)</p>\n</td>\n<td>\n<p>N -Acetylgalactosamine-&alpha;-4-sulfate sulfatase (arylsulfatase B)</p>\n</td>\n<td>\n<p>Galsulfase (Naglazyme)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Sly syndrome (MPS VII)</p>\n</td>\n<td>&beta;-Glucuronidase</td>\n<td>\n<p>rhGUS (recombinant human&nbsp;&beta;-Glucuronidase is under Phase III trial)</p>\n</td>\n</tr>\n<tr>\n<td>Wolman disease</td>\n<td>Lysosomal acid lipase</td>\n<td>\n<p><em> Sebelipase alfa</em>(Kanuma, Alexion)</p>\n</td>\n</tr>\n<tr>\n<td>Metachromatic leukodystrophy</td>\n<td>Arylsulfatase A</td>\n<td>\n<p>rhARSA (recombinant human arylsulfatase A is under Phase I/II trial)</p>\n</td>\n</tr>\n<tr>\n<td>Fabry disease&nbsp;</td>\n<td>&alpha;-galactosidase A</td>\n<td>\n<p><em>agalsidase beta</em> (Fabrazyme, Genzyme)</p>\n<p><em>agalsidase alfa</em> (Replagal, Shire HGT)</p>\n</td>\n</tr>\n<tr>\n<td>Gaucher disease</td>\n<td>&beta;-glucosidase</td>\n<td>\n<p><em>imiglucerase </em>[Cerezyme, Genzyme]</p>\n<p><em>velaglucerase alfa </em>[VPRIV, Shire HGT]</p>\n<p><em>taliglucerase alfa </em>(Uplyso, Protalix<br />Biotherapeutics)</p>\n<p><em>eliglusta</em>t (Cerdelga, Sanofi-Genzyme)</p>\n</td>\n</tr>\n<tr>\n<td>Pompe disease</td>\n<td>acid &alpha;-1,4-glucosidase (acid maltase)&nbsp;</td>\n<td>\n<p><em>alglucosidase alfa </em>(Myozyme)</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Diseases due to glycoprotein defect</h3><table>\n<tbody>\n<tr>\n<td><strong>Diseases</strong></td>\n<td><strong>Defect</strong></td>\n<td><strong>Characteristics</strong></td>\n</tr>\n<tr>\n<td>I-cell disease</td>\n<td>Mutation in GNPTA gene leading to a deficiency in enzyme UDP-N-acetylglucoseamine-1-phosphotransferase</td>\n<td>\n<ul>\n<li>Coarse facial features</li>\n<li>Corneal erosion</li>\n<li>Failure to thrive</li>\n<li>Hepatomegaly</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Leukocyte adhesion deficiency, type II</td>\n<td>Mutations affecting activity of Golgi-located GDP-fucose transporter </td>\n<td>\n<ul>\n<li>Neutrophil rolling</li>\n<li>Life-threatening, recurrent bacterial infections</li>\n<li>Psychomotor and mental retardation</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Paroxysmal nocturnal hemoglobinuria</td>\n<td>Genetic mutation leading to the inability to synthesize the glycosyl-phosphatidylinositol (GPI) anchor that binds certain surface proteins to cell membranes.</td>\n<td>\n<ul>\n<li>Lysis of red cells</li>\n<li>Abdominal pain</li>\n<li>Back pain</li>\n<li>Esophageal spasms</li>\n<li>Erectile dysfunction</li>\n<li>Fatigue</li>\n<li>Progressive chronic renal failure</li>\n<li>Thrombophilia</li>\n<li>Bone marrow failure</li>\n<li>Venous thrombosis</li>\n<li>Aplastic anemia</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Ehlers–Danlos syndrome</td>\n<td>Deficiency or mutation in Lysyl hydroxylase-1  </td>\n<td>\n<ul>\n<li>Neonatal kyphoscoliosis</li>\n<li>Generalized joint laxity</li>\n<li>Skin fragility</li>\n<li>Severe muscle hypotonia at birth</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Oligosaccharidoses</td>\n<td>Lack of a specific lysosomal hydrolase for glycoproteins</td>\n<td>\n<ul>\n<li>Delay in intellectual and physical development.</li>\n<li>Seizure</li>\n<li>Joint stiffness and pain</li>\n<li>Problems with vision and hearing</li>\n<li>Anaemia, nose bleeds, and easy bleeding or bruising</li>\n<li>Swollen abdomen due to enlarged spleen or liver. </li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Congenital disorders of glycosylation  </td>\n<td>Glycosylation of a variety of tissue proteins and/or lipids is deficient or defective</td>\n<td>\n<ul>\n<li>Fatal, malfunction of several different organ systems</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Familial tumoral calcinosis (FTC)</td>\n<td>UDP-GalNAc transferase 3</td>\n<td>\n<ul>\n<li>Calcium deposits in skin and subcutaneous tissues</li>\n<li>Unresponsiveness to parathyroid hormone</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Walker–Warburg syndrome (WWS)</td>\n<td>Defective α-dystroglycan</td>\n<td>\n<ul>\n<li>Agenesis of corpus callosum</li>\n<li>Anal atresia</li>\n<li>Atresia of the external auditory canal</li>\n<li>Blindness</li>\n<li>Buphthalmos</li>\n<li>Cerebellar dysplasia</li>\n<li>Cleft upper lip</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Hereditary erythroblastic multinuclearity with positive acidified serum lysis test (HEMPAS)</td>\n<td>Defects in alpha–mannosidase II</td>\n<td>\n<ul>\n<li>Ineffective erythropoiesis</li>\n<li>Haemolysis &amp; erythroblast morphological abnormalities</li>\n<li>Hypoglycosylation of some red blood cell (RBC) membrane proteins</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/b1145ee9064e441ab0c05967cc443a1a.PNG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF4033",
      "difficulty": "easy"
    },
    {
      "text": "Match the enzyme with the disease caused by its deficiency.<div class='question-desc-html'><table>\n<tbody>\n<tr>\n<td>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;<strong>Enzyme</strong></td>\n<td>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;<strong>Disease</strong></td>\n</tr>\n<tr>\n<td>&nbsp;1. Glucose-6-phosphatase</td>\n<td>a. Cori's disease</td>\n</tr>\n<tr>\n<td>&nbsp;2. Muscle phosphofructokinase</td>\n<td>b. McArdle's disease&nbsp;</td>\n</tr>\n<tr>\n<td>&nbsp;3.&nbsp;Muscle glycogen phosphorylase</td>\n<td>c. von Gierke disease</td>\n</tr>\n<tr>\n<td>&nbsp;4.&nbsp;Glycogen debranching enzyme</td>\n<td>d. Tarui's disease</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div></div>",
      "choices": [
        {
          "id": 1,
          "text": "1-c, 2-a, 3-d, 4-b"
        },
        {
          "id": 2,
          "text": "1-c, 2-d, 3-b, 4-a"
        },
        {
          "id": 3,
          "text": "1-a, 2-c, 3-d, 4-b"
        },
        {
          "id": 4,
          "text": "1-a, 2-d. 3-b, 4-c"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<table>\n<tbody>\n<tr>\n<td>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;<strong>Enzyme</strong></td>\n<td>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;<strong>Disease</strong></td>\n</tr>\n<tr>\n<td>1. Glucose-6-phosphatase</td>\n<td>\n<p>c. von Gierke disease</p>\n</td>\n</tr>\n<tr>\n<td>2. Muscle phosphofructokinase</td>\n<td>\n<p>d. Tarui's&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>3.&nbsp;Muscle glycogen phosphorylase</td>\n<td>\n<p>b. McArdle disease&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>4.&nbsp;Glycogen debranching enzyme</td>\n<td>\n<p>a. Cori's disease</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p><strong>Von Gierke disease&nbsp;</strong>(Type Ia glycogen storage disorder)<strong>&nbsp;</strong>occurs due to<strong>&nbsp;</strong>a&nbsp;deficiency&nbsp;of<strong>&nbsp;glucose-6-phosphatase</strong>&nbsp;enzyme in the liver, kidney, and intestinal mucosa. Patients&nbsp;present commonly by 3-4 months of age with<strong>&nbsp;hypoglycemia&nbsp;</strong>(leading to&nbsp;<strong>seizures</strong>),<strong>&nbsp;lactic acidosis,&nbsp;</strong>and&nbsp;<strong>hepatomegaly.&nbsp;</strong>Affected children often have a<strong>&nbsp;doll-like face</strong>&nbsp;with fat cheeks, relatively thin extremities, short stature, and a protuberant abdomen due to&nbsp;<strong>massive hepatomegaly.&nbsp;</strong>The&nbsp;<strong>kidneys&nbsp;</strong>are also<strong>&nbsp;enlarged,&nbsp;</strong>whereas the spleen and heart are not involved.&nbsp;Laboratory findings include&nbsp;hypoglycemia, lactic acidosis,<strong>&nbsp;hyperuricemia,&nbsp;</strong>and&nbsp;<strong>hyperlipidemia.</strong></p>\n<p><strong>Tarui disease</strong>&nbsp;(Type VII glycogen storage disorder)<strong>&nbsp;</strong>occurs due to the deficiency of <strong>phosphofructokinase</strong>. The main clinical features are exercise intolerance, cramps,&nbsp;<strong>hemolytic anemia,</strong>&nbsp;and <strong>myoglobinuria</strong>.</p>\n<p><strong>McArdle disease&nbsp;</strong>(Type V glycogen storage disorder)&nbsp;occurs due to&nbsp;<strong>myophosphorylase</strong>&nbsp;deficiency. It appears in&nbsp;<strong>late childhood</strong>&nbsp;or the second decade of life. The typical manifestations are muscle pain and cramps after heavy exercise. This pain may reduce after a brief period of rest and the patient may be able to perform an exercise. This is called the&nbsp;<strong>second wind phenomenon</strong>.</p>\n<p><strong>Glycogen debranching enzyme deficiency</strong>&nbsp;is seen in&nbsp;<strong>Cori's disease</strong> (type III glycogen storage disorder). Failure to debranch glycogen into glucose subunits results in the accumulation of abnormal glycogen with short outer-branch chains which resemble<strong> limit dextrin</strong>. These children present with <span>hepatomegaly, hypoglycemia, short stature, variable skeletal myopathy, and variable cardiomyopathy.</span></p><hr><h3>Related Pearl: Glycogen Storage Diseases</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/782e85c36f0648698a222dca988adfabx1280x1863.JPEG\" alt=\"Pearl Image\"><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Disease</strong></p>\n</td>\n<td>\n<p><strong>Enzyme deficiency</strong></p>\n</td>\n<td>\n<p><strong>Symptoms</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>GSD type 0</p>\n</td>\n<td>\n<p>Glycogen synthase</p>\n</td>\n<td>\n<p>Hypoglycemia</p>\n<p>Early death</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>GSD type Ia</p>\n<p><strong>Von Gierke's disease</strong></p>\n</td>\n<td>\n<p>Glucose-6- phosphatase</p>\n</td>\n<td>\n<p>Hepatomegaly and renomegaly&nbsp;due to glycogen accumulation</p>\n<p>Severe fasting hypoglycemia</p>\n<p>Growth failure</p>\n<p>Lactic acidosis</p>\n<p>Hyperuricemia</p>\n<p>Hyperlipidemia</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>GSD type Ib</p>\n</td>\n<td>\n<p>Endoplasmic reticulum glucose-6- phosphate transporter</p>\n</td>\n<td>\n<p>Same as Von Gierke's disease</p>\n<p>Recurrent infections due to impaired neutrophil function</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>GSD type II</p>\n<p><strong>Pompe's disease</strong></p>\n</td>\n<td>\n<p>Lysosomal &alpha;1,4:1,6 glucosidase</p>\n<p>(Acid maltase)</p>\n</td>\n<td>\n<p>Muscle weakness</p>\n<p>Death by age ~ 2 years (infantile variant)</p>\n<p>Cardiomegaly and heart failure</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>GSD type III</p>\n<p><strong>Cori's/Forbes disease</strong></p>\n<p>(Limit dextrinosis)</p>\n</td>\n<td>\n<p>Glycogen debranching enzyme</p>\n</td>\n<td>\n<p>Muscle weakness</p>\n<p>Fasting hypoglycemia</p>\n<p>Hepatomegaly due to accumulation of branched-chain polysaccharide (limit dextrins)</p>\n<p>Growth retardation</p>\n<p>Normal lactate and uric acid levels</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>GSD type IV</p>\n<p><strong>Andersen disease</strong></p>\n</td>\n<td>\n<p>Glycogen branching enzyme</p>\n</td>\n<td>\n<p>Failure to thrive</p>\n<p>Hepatomegaly due to accumulation of polysaccharides with few branch points</p>\n<p>Death at age ~ 5 years</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>GSD type V</p>\n<p><strong>McArdle disease</strong></p>\n</td>\n<td>\n<p>Muscle glycogen phosphorylase</p>\n</td>\n<td>\n<p>Exercise-induced cramps</p>\n<p>Renal failure due to rhabdomyolysis and myoglobinuria</p>\n<p>Second wind phenomenon</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>GSD type VI</p>\n<p><strong>Her's disease</strong></p>\n</td>\n<td>\n<p>Liver glycogen phosphorylase</p>\n</td>\n<td>\n<p>Generally benign</p>\n<p>Mild hypoglycemia</p>\n<p>Hepatomegaly</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>GSD type VII</p>\n<p><strong>Tarui's disease</strong></p>\n</td>\n<td>\n<p>Muscle phosphofructokinase</p>\n</td>\n<td>\n<p>Exercise-induced muscle cramps and weakness</p>\n<p>Growth retardation</p>\n<p>Hemolytic anemia</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF3822",
      "difficulty": "easy"
    },
    {
      "text": "A 2-year-old male child was accompanied by his father to the OPD with dry, scaly dermatitis. On evaluation, he had a deficiency of essential fatty acids. Deficiency of which of the following would have likely caused this child's presentation?",
      "choices": [
        {
          "id": 1,
          "text": "Oleic acid"
        },
        {
          "id": 2,
          "text": "Palmitoleic acid"
        },
        {
          "id": 3,
          "text": "Linoleic acid"
        },
        {
          "id": 4,
          "text": "Arachidonic acid"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The <strong>deficiency</strong> of the&nbsp;<strong>essential fatty acid</strong>,<strong>&nbsp;linoleic acid</strong>, is likely to have caused this child's presentation of&nbsp;dry and<strong> scaly</strong> <strong>dermatitis.</strong></p>\n<p>Essential fatty acid (EFA) refers to polyunsaturated fatty acids (PUFA) <strong>required for biological processes</strong> but is <strong>not synthesized</strong> by the body.</p>\n<p>The two essential fatty acids in humans are as follows:</p>\n<ul>\n<li><strong>Linoleic acid&nbsp;(Omega 6)</strong>: It is the precursor of <strong>arachidonic acid</strong></li>\n<li><strong>&alpha;-Linolenic acid&nbsp;(Omega 3)</strong>: It is the precursor of <strong>eicosapentaenoic acid and docosahexaenoic acid.</strong></li>\n</ul>\n<p><strong>Clinical Significance of PUFA and EFA</strong></p>\n<div class=\"page\" title=\"Page 203\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<ol>\n<li>PUFAs are used for <strong>esterification </strong>and <strong>excretion of cholesterol</strong>.</li>\n<li>Deficiency of EFA causes <strong>acanthocytosis, hyperkeratosis,</strong> <strong>acrodermatitis,</strong> and <strong>hypercholesterolemia</strong>.</li>\n<li>EFA deficiency is connected with <strong>acrodermatitis enteropathica, hepatorenal syndrome,</strong> and <strong>CNS manifestations.</strong></li>\n<li><strong>Elevated PUFA </strong>levels are seen in <strong>Zellweger&rsquo;s syndrome.</strong></li>\n<li><strong>DHA levels</strong> in the blood are<strong> low</strong> in patients with <strong>retinitis pigmentosa</strong>.</li>\n<li><strong>Trans fatty acids</strong> will<strong> compete</strong> with <strong>EFAs</strong> and may increase the EFA deficiency and <strong>decrease</strong> the <strong>fluidity of membranes.</strong></li>\n</ol>\n</div>\n</div>\n</div>\n</div>\n<p>Other options:</p>\n<p>Options A &amp; B: <strong>Oleic</strong> and <strong>palmitoleic acids</strong> are <strong>non-essential</strong> fatty acids. They can be synthesized in the body naturally.&nbsp;</p>\n<p>Option D: <strong>Arachidonic acid </strong>is <strong>non-essential fatty acid</strong> as it can be synthesized from&nbsp;<strong>linoleic acid.</strong></p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF4318",
      "difficulty": "medium"
    },
    {
      "text": "A scientist is trying to develop a drug for a genetic condition. He seeks a drug that could cause epigenetic alteration in the DNA and could prevent the disease or seemingly improve the condition. All the following would include epigenetic modifications, except _______.",
      "choices": [
        {
          "id": 1,
          "text": "Altering the gene sequence of DNA"
        },
        {
          "id": 2,
          "text": "Histone methylation"
        },
        {
          "id": 3,
          "text": "DNA methylation at CpG islands in promoter regions"
        },
        {
          "id": 4,
          "text": "Histone acetylation"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Epigenetic changes </strong>are&nbsp;<strong>heritable chemical changes</strong> in <strong>gene expression&nbsp;</strong>that are&nbsp;not&nbsp;caused by the&nbsp;alteration in the gene sequence. They&nbsp;<strong>alter&nbsp;</strong>gene <strong>expression without mutation</strong>.</p>\n<p>The term &ldquo;epigenetics&rdquo; means &ldquo;above genetics.&rdquo; It refers to the regulatory mechanisms that <strong>do not change</strong> the<strong> underlying regulated DNA sequence</strong>, but rather <strong>change </strong>the<strong> expression patterns</strong>, or<strong> function</strong>, of the DNA. Epigenetic mechanisms play key roles in the establishment, maintenance, and reversibility of transcriptional states. It can&nbsp;cause <strong>both&nbsp;gene activation </strong>and <strong>inactivation</strong>.</p>\n<div class=\"ng-star-inserted\">\n<div class=\"table-responsive font-weight-light answer-scroll ng-star-inserted\">\n<p>Epigenetic modifications include</p>\n<ol>\n<li><strong>DNA methylation- </strong>It&nbsp;is the covalent addition and subtraction of a methyl group to DNA. Methylation is typically done in&nbsp;cytosine preceding a guanine (<strong>CpG)</strong> dinucleotides. CpG islands are mainly present in the <strong>promoter</strong> region.</li>\n<li><strong>Histone modifications</strong> such as <strong>acetylation</strong>,&nbsp;deacetylation,<strong>&nbsp;methylation,</strong>&nbsp;phosphorylation, etc. Acetylation of histone activates transcription, while deacetylation represses transcription.</li>\n<li><strong>miRNA-&nbsp;</strong>micro RNA or miRNA are approximately 22 nucleotides long. They do not code. They bind to mRNA and inhibit its translation.</li>\n</ol>\n</div>\n</div><p><strong>Clinical</strong><strong>&nbsp;significance of epigenetic mechanisms:</strong></p>\n<ul>\n<li>Epigenetic modifications, such as histone acetylation and DNA methylation, are&nbsp;<strong>reversible,</strong>&nbsp;which makes them amenable for application in therapeutic intervention.</li>\n<li><strong>Histone deacetylase (HDAC) inhibitors</strong>&nbsp;and&nbsp;<strong>DNA methylation inhibitors</strong>&nbsp;are being tested in the treatment of cancer. These agents inhibit transcriptional silencing and thus reverse the chromatin condensation in cancer cells.</li>\n<li class=\"p1\">These modifications include&nbsp;<strong>heritable changes</strong>&nbsp;such as X-inactivation and <strong>genomic imprinting</strong>, but they can also result from dynamic post-translational protein modifications in response to environmental influences such as diet, age, and drugs.</li>\n</ul><hr><h3>Related Pearl: Role of Histones</h3><table>\n<tbody>\n<tr>\n<td>\n<p>Types</p>\n</td>\n<td>\n<p>Function</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>H1 histones</p>\n</td>\n<td>\n<p>Stabilize the 30-nm chromatin fiber</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>H2 histones</p>\n</td>\n<td>\n<p>H2A&ndash;H2B dimers stabilize the primary particle and firmly bind two additional half-turns of DNA</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>H3 histones</p>\n</td>\n<td rowspan=\"2\">\n<p>(H3&ndash;H4)2 tetramer has a central role in the formation</p>\n<p>of the nucleosome</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>H4 histones</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD9876",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following region of mRNA offers protection from 3′ → 5′ exonuclease activity?",
      "choices": [
        {
          "id": 1,
          "text": "Guanyl Cap"
        },
        {
          "id": 2,
          "text": "TATA box"
        },
        {
          "id": 3,
          "text": "Poly A tail"
        },
        {
          "id": 4,
          "text": "Shine-Dalgarno Sequence"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<div class=\"page\" title=\"Page 422\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>The poly(A) tail protects the 3&prime; end of mRNA from 3&prime; &rarr; 5&prime; exonuclease attack and facilitates translation.</p>\n<p>Eukaryotic messenger RNA usually undergoes post-transcriptional modification and polyadenylation is an important part of this post-transcriptional modification.&nbsp;They help to&nbsp;<strong>stabilize</strong> the mRNA, facilitate its exit from the nucleus, and aid in translation. After the mRNA enters the cytosol, the poly-A tail is gradually shortened.&nbsp; Eukaryotic mRNAs have <strong>poly-A tails at 3' end</strong> and&nbsp;<strong>7-methylguanosine caps</strong> <strong>at 5' end.</strong></p>\n</div>\n</div>\n</div>\n</div>\n<p>Other options:</p>\n<p>Option A: The attachment of mRNA to the ribosome is mediated through the <strong>guanyl&nbsp;cap</strong> at the 5' end. It also prevents the attack of&nbsp;5&prime;&rarr;&nbsp;3&prime;&nbsp;exonucleases</p>\n<p>Option B: TATA box is the site of pre-initiation complex formation, which is the first step in transcription initiation.</p>\n<p>Option D:<strong> Shine-Dalgarno sequence</strong> initiates translation in <strong>prokaryotes.</strong></p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD2200",
      "difficulty": "medium"
    },
    {
      "text": "A patient diagnosed with primary hyperoxaluria is most likely to have a deficiency of which of the following amino acids?",
      "choices": [
        {
          "id": 1,
          "text": "Threonine"
        },
        {
          "id": 2,
          "text": "Serine"
        },
        {
          "id": 3,
          "text": "Glycine"
        },
        {
          "id": 4,
          "text": "Alanine"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>A patient diagnosed with <strong>primary hyperoxaluria</strong> is most likely to have a <strong>glycine</strong> deficiency.</p>\n<p>Primary hyperoxalurias are a group of inborn errors of metabolism characterized by oxalate overproduction, with an autosomal recessive inheritance. There are 3 types of primary hyperoxalurias, of which primary hyperoxaluria type 1 (PH1) is the most common form.</p>\n<p>The defect in PH1 is the <strong>deficiency</strong> of the <strong>alanine</strong>-<strong>glyoxylate aminotransferase</strong> in liver peroxisomes. This causes failure to catabolize glyoxylate to glycine. Glyoxylate is instead converted to <strong>oxalate</strong>, with consequent <strong>calcium oxalate stone formation</strong> and crystal deposition in various organs like the kidney. </p>\n<p>Age at onset of symptoms ranges from infancy to the sixth decade, with the median age being 4–6 years. Presenting symptoms include hematuria, dysuria, pain, urinary tract infection, or stone passage. In severe, early-onset disease, there is nephrocalcinosis with or without nephrolithiasis and failure to thrive related to renal failure.</p>\n<p>A urinalysis shows <strong>elevated urinary oxalate</strong> and elevated urinary glycolic acid. There is also an <strong>elevated</strong> level of <strong>plasma</strong> <strong>oxalate</strong>. Renal <strong>ultrasound</strong> may show multiple bilateral radiopaque <strong>calculi</strong>. </p><p>The FDA recently approved lumasiran, an RNA interference therapeutic agent targeting glycolate oxidase, as the first treatment option for PH1, a rare genetic disorder.</p><hr><h3>Related Pearl: Amino acid Enzymatic Disorders and the Associated Enzymes</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Disorder</strong></p>\n</td>\n<td>\n<p><strong>Enzyme defect</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Phenylketonuria</p>\n</td>\n<td>\n<p>Phenylalanine hydroxylase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Tyrosinosis (Tyrosinemia type I)</p>\n</td>\n<td>\n<p>Maleyl Acetate isomerase or Fumarylacetoacetate hydrolase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Maple syrup urine disease&nbsp;</p>\n</td>\n<td>\n<p>Branched-chain alpha-keto acid dehydrogenase(BCKAD)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Alkaptonuria</p>\n</td>\n<td>\n<p>Homogentisate oxidase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Albinism</p>\n</td>\n<td>\n<p>Tyrosinase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Homocystinuria type I</p>\n</td>\n<td>\n<p>Cystathionine synthase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Homocystinuria type II</p>\n</td>\n<td>\n<p>Defect in methylcobalamin formation</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Cystathioninuria</p>\n</td>\n<td>\n<p>Cystathionase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Tyrosinemia type II or Richner-Hanhart syndrome</p>\n</td>\n<td>\n<p>Tyrosine transaminase or Tyrosine aminotransferase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Primary hyperoxaluria</p>\n</td>\n<td>\n<p>Alanine glyoxalate aminotransferase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hypervalinemia</p>\n</td>\n<td>\n<p>Valine transaminase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Isovaleric acidemia</p>\n</td>\n<td>\n<p>Isovaleryl CoA dehydrogenase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Histidinemia</p>\n</td>\n<td>\n<p>Histidase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hyperprolinemia type I</p>\n</td>\n<td>\n<p>Proline oxidase</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF3523",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following conditions ensues when there is a deficiency of the rate-limiting enzyme in the urea cycle?",
      "choices": [
        {
          "id": 1,
          "text": "Hyperammonemia type 2"
        },
        {
          "id": 2,
          "text": "Hyperammonemia type 1"
        },
        {
          "id": 3,
          "text": "HHH syndrome"
        },
        {
          "id": 4,
          "text": "Type 1 tyrosinemia"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>Carbamoyl phosphate synthetase I <strong>(CPS1)</strong>&nbsp;is the rate-limiting enzyme of the urea cycle. The deficiency of this enzyme results in&nbsp;<strong>Hyperammonemia type 1.</strong></p>\n<p>Carbamoyl phosphate synthetase I utilize CO<sub><span class=\"s1\">2</span></sub>, ammonia, and 2ATPs to form carbamoyl phosphate.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/17dc01c39f5245f498ef54b95867b976x1013x249.JPEG\" alt=\"Explanation Image\"><p>&nbsp;</p>\n<p>Other options:</p>\n<ul>\n<li>Deficiency of&nbsp;ornithine Transcarbamoylase results in&nbsp;<strong>hyperammonemia type 2.</strong></li>\n<li>Deficiency of ornithine Permease results in hyperornithinemia, hyperammonemia, and homocitrullinuria (<strong>HHH</strong>) syndrome.</li>\n<li>Deficiency of fumarylacetoacetate hydrolase results in <strong>type 1 tyrosinemia.</strong></li>\n</ul><hr><h3>Related Pearl: Urea Cycle and its disorders</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/18bcc23295f14f9f9b7463912fdb6eeax1280x2235.JPEG\" alt=\"Pearl Image\"><hr><h3>Related Pearl: Types of tyrosinemia  with deficient enzymes</h3><table>\n<tbody>\n<tr>\n<td>\n<div><strong>Disease</strong></div>\n</td>\n<td>\n<div><strong>Enzyme-deficient</strong></div>\n</td>\n</tr>\n<tr>\n<td>\n<div>Tyrosinemia type 1 (Hepatorenal, Hereditary tyrosinemia, Tyrosinosis)</div>\n</td>\n<td>\n<div>Fumarylacetoacetate hydrolase (FAAH)</div>\n</td>\n</tr>\n<tr>\n<td>\n<div>Tyrosinemia type 2 (Oculocutaneous)</div>\n</td>\n<td>\n<div>Tyrosine aminotransferase</div>\n</td>\n</tr>\n<tr>\n<td>\n<div>Tyrosinemia type 3 (Neonatal tyrosinemia)</div>\n</td>\n<td>\n<div>4-Hydroxyphenylpyruvate dioxygenase (4-HPPD)</div>\n</td>\n</tr>\n<tr>\n<td>\n<div>Hawkinsinuria</div>\n</td>\n<td>\n<div>Missense mutations in the gene for 4-HPPD</div>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD4045",
      "difficulty": "medium"
    },
    {
      "text": "A 6-month-old child was brought to the outpatient clinic with features of hypotonia, irritability, and exaggerated startle response. Development milestones were delayed. Fundoscopic examination revealed the finding as shown in the image below. Which of the following enzymes is deficient in this condition?",
      "choices": [
        {
          "id": 1,
          "text": "α-Galactosidase"
        },
        {
          "id": 2,
          "text": "Arylsulfatase A"
        },
        {
          "id": 3,
          "text": "β-Hexosaminidase A"
        },
        {
          "id": 4,
          "text": "β-Glucosidase"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The given clinical scenario of an infant presenting with hypotonia, irritability, exaggerated startle response, delayed milestones, and the image showing the cherry-red spot point to the diagnosis of <strong>Tay-Sachs disease</strong>. The enzyme <strong>deficient</strong> in this condition is <strong>β-hexosaminidase A.</strong></p>\n<p>Tay-Sachs disease is a lipid storage disorder due to the deficiency<strong> </strong>of<strong> </strong>hexosaminidase<strong> </strong>A leading to the <strong>accumulation</strong> of<strong> GM2 gangliosides. </strong>It is classified into infantile, juvenile, and adult-onset forms based on the age at onset and clinical features.</p>\n<p>Affected infants usually develop normally until 4-5 months of age. Clinical features of Tay-Sachs disease include:</p>\n<ul>\n<li><strong>Muscle weakness (hypotonia)</strong></li>\n<li>Seizures</li>\n<li><strong>Exaggerated startle response</strong></li>\n<li>Macrocephaly</li>\n<li>Mental retardation</li>\n<li><strong>Macular</strong> <strong>cherry-red spots</strong></li>\n<li>Blindness</li>\n<li><strong>Developmental delay</strong></li>\n</ul>\n<p>The deficiency of <strong>β-hexosaminidase A </strong>and<strong> B</strong> causes <strong>Sandhoff's</strong> <strong>disease</strong>. The clinical manifestations of Sandhoff disease are similar to those of Tay-Sachs disease. Infants with Sandhoff disease have hepatosplenomegaly, cardiac involvement, and mild bony abnormalities.</p><p>Other options:</p>\n<p>Option A: <strong>Fabry disease</strong> is an <strong>X-linked</strong><strong> lysosomal storage disorder</strong> caused due to deficiency of <strong>α-Galactosidase. </strong>This leads to the accumulation of <strong>globotriaosylceramide</strong>. Clinical features include angiokeratomas, hypohidrosis, corneal and lenticular opacities, and painful acroparesthesias. <strong>Angiokeratomas</strong> are dark red to blue-black, flat or slightly raised, punctate lesions, usually seen between the umbilicus and the knees (called the <strong>bathing suit area</strong>) and the trunk.</p>\n<p>Option B: <strong>Metachromatic leukodystrophy</strong> is a <strong>lysosomal storage disease</strong> caused due to deficiency of the enzyme <strong>arylsulfatase A</strong>. It leads to demyelination and the patient has a neurodegenerative course.</p>\n<p>Option D: <strong>Gaucher disease</strong> is an <strong>autosomal recessive </strong>lysosomal storage disorder with a deficiency of <strong>acid-β-glucosidase.</strong> It leads to the accumulation of <strong>glucosylceramide.</strong> The features of this disease include growth retardation, <strong>hepatosplenomegaly,</strong> thrombocytopenia, anemia, and <strong>Erlenmeyer flask deformity</strong> of the distal femur. Histology shows the presence of <strong>Gaucher cells </strong>with a characteristic <strong>wrinkled</strong>-<strong>paper</strong> <strong>appearance</strong>. <strong>Mental retardation</strong> is seen in <strong>infants</strong>. </p><hr><h3>Related Pearl: Examples of Sphingolipidoses (Lipids-Storage Disease)</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/eaf86bca861342ff84c303230efbb8bax1280x2017.JPEG\" alt=\"Pearl Image\"><table>\n<tbody>\n<tr>\n<td>\n<p><strong>S. No.</strong></p>\n</td>\n<td>\n<p><strong>Disease</strong></p>\n</td>\n<td>\n<p><strong>Enzyme Deficiency</strong></p>\n</td>\n<td>\n<p><strong>Lipid </strong></p>\n<p><strong>Accumulating</strong></p>\n</td>\n<td>\n<p><strong>Clinical Symptoms</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>1</p>\n</td>\n<td>\n<p>Tay–Sachs disease</p>\n</td>\n<td>\n<p>Hexosaminidase A</p>\n</td>\n<td>\n<p>Ganglioside</p>\n</td>\n<td>\n<p>Mental retardation, blindness, muscular weakness</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>2</p>\n</td>\n<td>\n<p>Sandhoff's disease</p>\n</td>\n<td>\n<p>Hexosaminidase A and B</p>\n</td>\n<td>\n<p>Globoside &amp; Ganglioside</p>\n</td>\n<td>\n<p>Similar to Tay–Sachs disease but also has hepatosplenomegaly and skeletal dysplasias</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>3</p>\n</td>\n<td>\n<p>Fabry's disease</p>\n</td>\n<td>\n<p>α-Galactosidase</p>\n</td>\n<td>\n<p>Globotriaosyl-ceramide</p>\n</td>\n<td>\n<p>Skin rash, kidney failure (full symptoms only in males; X-linked recessive)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>4</p>\n</td>\n<td>\n<p>Metachromatic leukodystrophy</p>\n</td>\n<td>\n<p>Arylsulfatase A</p>\n</td>\n<td>\n<p>3-Sulfogalactosyl-ceramide</p>\n</td>\n<td>\n<p>Mental retardation and psychologic disturbances in adults; demyelination</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>5</p>\n</td>\n<td>\n<p>Krabbe disease</p>\n</td>\n<td>\n<p>β-Galactosidase</p>\n</td>\n<td>\n<p>Galactosylceramide</p>\n</td>\n<td>\n<p>Mental retardation; myelin almost absent</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>6</p>\n</td>\n<td>\n<p>Gaucher's disease</p>\n</td>\n<td>\n<p>β-Glucosidase</p>\n</td>\n<td>\n<p>Glucosylceramide</p>\n</td>\n<td>\n<p>Enlarged liver and spleen, erosion of long bones, mental retardation in infants</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>7</p>\n</td>\n<td>\n<p>Niemann–Pick disease</p>\n</td>\n<td>\n<p>Sphingomyelinase</p>\n</td>\n<td>\n<p>Sphingomyelin</p>\n</td>\n<td>\n<p>Enlarged liver and spleen, mental retardation; fatal in early life</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>8</p>\n</td>\n<td>\n<p>Farber's disease</p>\n</td>\n<td>\n<p>Ceramidase</p>\n</td>\n<td>\n<p>Ceramide</p>\n</td>\n<td>\n<p>Hoarseness, dermatitis, skeletal deformation, mental retardation; fatal in early life</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/69213fe9e73c4df08f1a9d120f55f7a0.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD4052",
      "difficulty": "easy"
    },
    {
      "text": "Choose the option in which the enzyme and its function are incorrectly matched.",
      "choices": [
        {
          "id": 1,
          "text": "DNA polymerase - involved in deoxynucleotide polymerization"
        },
        {
          "id": 2,
          "text": "Helicase - prevents premature reannealing of double-stranded DNA"
        },
        {
          "id": 3,
          "text": "Topoisomerase - relieves torsional strain caused by unwinding of DNA"
        },
        {
          "id": 4,
          "text": "DNA ligase - sealing nicks in DNA strands"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>Helicase is not involved in the prevention of premature reannealing of double-stranded DNA (dsDNA); this is the function of&nbsp;single-strand binding proteins (<strong>SSBs</strong>)</p>\n<p>Helicases belong to a class of proteins involved in DNA replication. They are involved in&nbsp;<strong>ATP-driven unwinding of DNA.</strong></p>\n<p>Other options:</p>\n<p>Option A-<strong>&nbsp;DNA polymerases&nbsp;</strong>- Involved in deoxynucleotide polymerization</p>\n<p><span>Option B-<strong> Topoisomerases&nbsp;</strong>- Relieve torsional strain resulting from unwinding</span></p>\n<p>Option D-&nbsp;<strong>DNA ligase&nbsp;</strong>- Seals nicks in the DNA strand during replication</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/d9e1b6352a584242b80cac6a08678d3bx1280x1866.JPEG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Enzymes Involved in DNA Replication</h3><p>Prokaryotic DNA replication enzymes and their function:</p>\n<table>\n<tbody>\n<tr>\n<td>Enzyme</td>\n<td>Function</td>\n</tr>\n<tr>\n<td>DNA Polymerase I (Pol I)</td>\n<td>Gap filling following DNA replication, repair, and recombination</td>\n</tr>\n<tr>\n<td>DNA polymerase II (Pol II)</td>\n<td>DNA proofreading and repair</td>\n</tr>\n<tr>\n<td>DNA polymerase III (Pol III)</td>\n<td>\n<p>Processive, leading strand synthesis, DNA proofreading</p>\n</td>\n</tr>\n<tr>\n<td>DnaG</td>\n<td>\n<p>Primase&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>Helicase</td>\n<td>ATP-driven processive unwinding of DNA.</td>\n</tr>\n<tr>\n<td>Primase</td>\n<td>Initiates synthesis of RNA primers.</td>\n</tr>\n<tr>\n<td>Topoisomerase</td>\n<td>Relieve torsional strain that results from helicase-induced unwinding.</td>\n</tr>\n<tr>\n<td>Single-strand binding proteins (SSBs)</td>\n<td>Prevents premature reannealing of dsDNA.</td>\n</tr>\n<tr>\n<td>DNA ligase</td>\n<td>Seals the single strand nick between the nascent chain and Okazaki fragments on lagging strand.</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>\n<p>Eukaryotic DNA polymerases:</p>\n<table>\n<tbody>\n<tr>\n<td>Eukaryotic DNA Polymerases</td>\n<td>Functions</td>\n<td>Proofreading</td>\n</tr>\n<tr>\n<td>&alpha;&nbsp;</td>\n<td>Primase (initiates DNA synthesis)</td>\n<td>-</td>\n</tr>\n<tr>\n<td><em>&beta;</em></td>\n<td>DNA repair</td>\n<td>-</td>\n</tr>\n<tr>\n<td>\n<p>&gamma;</p>\n</td>\n<td>Mitochondrial DNA synthesis</td>\n<td>+</td>\n</tr>\n<tr>\n<td>&nbsp;&delta;&nbsp;</td>\n<td>Processive, lagging strand synthesis(forms and elongates Okazaki fragments from primer)</td>\n<td>+</td>\n</tr>\n<tr>\n<td>&nbsp;<em>&epsilon;&nbsp;</em></td>\n<td>Processive, leading strand synthesis</td>\n<td>+</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF1762",
      "difficulty": "medium"
    },
    {
      "text": "Fructose-2,6-bisphosphate is an allosteric regulator. Which of the following is true about fructose-2,6-bisphosphate?",
      "choices": [
        {
          "id": 1,
          "text": "Formed by phosphorylation of fructose-6-phosphate by phosphofructokinase-1"
        },
        {
          "id": 2,
          "text": "Positive allosteric regulator of phosphofructokinase-2"
        },
        {
          "id": 3,
          "text": "Fall in fructose-2,6-bisphosphate levels favors gluconeogenesis"
        },
        {
          "id": 4,
          "text": "Activator of fructose-1,6-bisphosphatase"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Option C</strong> is the correct statement. A&nbsp;<strong>fall</strong> in <strong>fructose 2,6 bisphosphate</strong> levels <strong>favors</strong> <strong>gluconeogenesis</strong>.</p>\n<p>This is a <strong>bifunctional&nbsp;enzyme</strong> and has the activity of both<strong>&nbsp;phosphofructokinase-II (PFK II) and fructose 2,6 bisphosphatase.&nbsp;</strong></p>\n<ul>\n<li>PFK-II converts fructose-6-phosphate to fructose-2,6-bisphosphate.&nbsp;</li>\n<li>Fructose-2,6-bisphosphatase converts fructose-2,6-bisphosphate to fructose-6-phosphate.&nbsp;</li>\n</ul>\n<p>Fructose-2,6-bisphosphate allosterically activates PFK-I, which is involved in converting&nbsp;fructose-6-phosphate to&nbsp;fructose-1,6-bisphosphate in glycolysis. In the<strong> well-fed state</strong>, <strong>fructose-2,6-bisphosphate</strong> acts as an intracellular signal that indicates that glucose is abundant, thereby causing an <strong>increase </strong>in the<strong> rate </strong>of<strong> glycolysis</strong>.&nbsp;</p>\n<p>In contrast, during fasting, there is the <strong>phosphorylation</strong> of this tandem enzyme by <strong>glucagon</strong>. This phosphorylation causes the <strong>inactivation</strong> of the <strong>PFK-II</strong> part and <strong>activation</strong> of the <strong>fructose-2,6-bis-phosphatase</strong> component. This results in a <strong>fall </strong>in<strong> fructose 2,6 bisphosphate levels</strong>, which&nbsp;<strong>favors gluconeogenesis</strong>.&nbsp;&nbsp;</p>\n<p>Other options:</p>\n<p>Option A: Fructose-2,6-bisphosphate is formed by the phosphorylation of fructose-6-phosphate by phosphofructokinase-2.</p>\n<p>Option B: Fructose-2,6-bisphosphate is the <strong>most potent</strong> positive <strong>allosteric activator</strong> of <strong>phosphofructokinase-1</strong>.</p>\n<p>Option D: Fructose-2,6-bisphosphate is an&nbsp;<strong>inhibitor</strong> of <strong>fructose-1,6-bisphosphatase</strong>.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD3360",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following is a substrate for gluconeogenesis?",
      "choices": [
        {
          "id": 1,
          "text": "Leucine"
        },
        {
          "id": 2,
          "text": "Acetoacetate"
        },
        {
          "id": 3,
          "text": "Propionyl CoA"
        },
        {
          "id": 4,
          "text": "Acetyl CoA"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>Among the given options, <strong>propionyl CoA</strong>&nbsp;acts as a <strong>substrate</strong> for<strong> gluconeogenesis</strong>.</p>\n<p>Gluconeogenesis is the <strong>synthesis </strong>of<strong> glucose </strong>from <strong>non-carbohydrate sources</strong>. Though it is an energy-consuming process, it is necessary to <strong>maintain blood glucose levels</strong>. It is needed as a fuel for erythrocytes and brain.</p>\n<p>Other substrates for gluconeogenesis include:</p>\n<ul>\n<li>Oxaloacetate is a direct precursor of phosphoenolpyruvate.</li>\n<li><strong>Pyruvate</strong>, an &alpha;-keto acid that can be converted to glucose.</li>\n<li>Glucogenic amino acids<strong>&nbsp;</strong>like&nbsp;<strong>alanine</strong>, cysteine, glycine, etc, by the actions of&nbsp;transaminases, yield pyruvate.<strong>&nbsp;</strong><strong>&nbsp;</strong></li>\n<li><strong>Lactate</strong>, obtained from anaerobic glycolysis,<strong>&nbsp;</strong>is&nbsp;released from skeletal muscles and RBCs into the blood. It is taken up by the liver via&nbsp;<strong>Cori cycle</strong>&nbsp;to be oxidized to pyruvate, to eventually synthesize glucose.</li>\n<li><strong>Glycerol</strong>&nbsp;from adipose tissue is converted to dihydroxyacetone phosphate in the liver, which itself is an intermediate of glycolysis and gluconeogenesis.</li>\n</ul>\n<p><strong>Acetyl CoA</strong> and compounds that give rise to acetyl CoA alone like <strong>acetoacetate</strong>, lysine, and <strong>leucine</strong> cannot give rise to a net synthesis of glucose. This is because of the&nbsp;<strong>irreversible&nbsp;</strong>nature of the&nbsp;<strong>pyruvate dehydrogenase&nbsp;</strong>complex, which converts pyruvate to acetyl CoA. These compounds give rise to ketone bodies instead.</p><hr><h3>Related Pearl: Irreversible enzymes in gluconeogenesis pathway</h3><p>The&nbsp;enzymes can be remembered using the mnemonic <strong>P</strong>athway <strong>P</strong>roduces <strong>F</strong>resh <strong>G</strong>lucose.</p>\n<table>\n<tbody>\n<tr>\n<td>Enzymes</td>\n<td>Reaction and site</td>\n<td>Cofactors</td>\n</tr>\n<tr>\n<td><strong>P</strong>yruvate carboxylase</td>\n<td>\n<p>Pyruvate &rarr; Oxaloacetate</p>\n<p>mitochondria</p>\n</td>\n<td>\n<p>Biotin, ATP</p>\n<p>Activated by acetyl-CoA</p>\n</td>\n</tr>\n<tr>\n<td><strong>P</strong>hosphoenolpyruvate carboxykinase</td>\n<td>Oxaloacetate&nbsp;&rarr; PhosphoenolPyruvate (cytosol)</td>\n<td>GTP</td>\n</tr>\n<tr>\n<td><strong>F</strong>ructose-1,6-bisphosphatase</td>\n<td>Fructose-1,6-bisphosphate&nbsp;&rarr; fructose-6-phosphate (cytosol)</td>\n<td>\n<p>Citrate(+ve)</p>\n<p>Fructose 2,6 bisphosphate (-ve)</p>\n</td>\n</tr>\n<tr>\n<td><strong>G</strong>lucose-6-phosphatase</td>\n<td>Glucose-6-phosphate&nbsp;&rarr; glucose Endoplasmic reticulum</td>\n<td>&nbsp;</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD7029",
      "difficulty": "medium"
    },
    {
      "text": "A 30-year-old female patient is very conscious about her body image. She started a diet having only 20 g per day of carbohydrate or less, but with unlimited consumption of fats and proteins. Her previous diet usually had an average of 100-120 g/day of carbohydrate. What will be the effect of this new diet plan?",
      "choices": [
        {
          "id": 1,
          "text": "Inhibits gluconeogenesis and promotes weight loss"
        },
        {
          "id": 2,
          "text": "Increases gluconeogenesis and promotes weight loss"
        },
        {
          "id": 3,
          "text": "Inhibits gluconeogenesis and promotes weight gain"
        },
        {
          "id": 4,
          "text": "Increases gluconeogenesis and promotes weight gain"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The given patient has adopted a <strong>very low carbohydrate diet </strong>as a new diet plan and this <strong>promotes weight loss </strong>and<strong> gluconeogenesis.</strong></p>\n<p>A very low carbohydrate diet, that is <strong>less than or equal to 20 grams per day</strong> of <strong>carbohydrates</strong> with unlimited consumption of fat and protein, has been promoted as an effective regime for weight loss. Since a lower amount of carbohydrates are consumed and there is a continual demand for glucose, gluconeogenesis from amino acids occurs. The associated high ATP cost is then met by the oxidation of fatty acids.</p>\n<p>A <strong>ketogenic diet</strong> is similar. It consists of <strong>high fats, moderate proteins, and very low carbohydrates</strong>. In a 2000 kcal per day ketogenic diet, <strong>carbohydrates</strong> should be <strong>20-50 grams per day.</strong></p>\n<p>When there is low carbohydrate availability, <strong>gluconeogenesis </strong>and<strong> ketogenesis</strong> come into action. When glucose availability drops further and, the endogenous gluconeogenesis cannot keep up with the needs of the body, ketogenesis begins. Ketone bodies replace glucose as a primary source of energy.</p>\n<p>During ketogenesis, due to low blood glucose feedback, insulin secretion is also low, which reduces fat and glucose storage. There is also an increased breakdown of fats that result in fatty acids, which get metabolized to ketone bodies. This metabolic state is referred to as 'nutritional ketosis.' The nutritional ketosis state is considered safe, as ketone bodies are produced in small concentrations without changes in blood pH. </p><hr><h3>Related Pearl: Irreversible enzymes in gluconeogenesis pathway</h3><p>The&nbsp;enzymes can be remembered using the mnemonic <strong>P</strong>athway <strong>P</strong>roduces <strong>F</strong>resh <strong>G</strong>lucose.</p>\n<table>\n<tbody>\n<tr>\n<td>Enzymes</td>\n<td>Reaction and site</td>\n<td>Cofactors</td>\n</tr>\n<tr>\n<td><strong>P</strong>yruvate carboxylase</td>\n<td>\n<p>Pyruvate &rarr; Oxaloacetate</p>\n<p>mitochondria</p>\n</td>\n<td>\n<p>Biotin, ATP</p>\n<p>Activated by acetyl-CoA</p>\n</td>\n</tr>\n<tr>\n<td><strong>P</strong>hosphoenolpyruvate carboxykinase</td>\n<td>Oxaloacetate&nbsp;&rarr; PhosphoenolPyruvate (cytosol)</td>\n<td>GTP</td>\n</tr>\n<tr>\n<td><strong>F</strong>ructose-1,6-bisphosphatase</td>\n<td>Fructose-1,6-bisphosphate&nbsp;&rarr; fructose-6-phosphate (cytosol)</td>\n<td>\n<p>Citrate(+ve)</p>\n<p>Fructose 2,6 bisphosphate (-ve)</p>\n</td>\n</tr>\n<tr>\n<td><strong>G</strong>lucose-6-phosphatase</td>\n<td>Glucose-6-phosphate&nbsp;&rarr; glucose Endoplasmic reticulum</td>\n<td>&nbsp;</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Ketogenesis</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/6d83bb1f03624a0486d7aad26f9fe2b8x1280x2005.JPEG\" alt=\"Pearl Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD4967",
      "difficulty": "medium"
    },
    {
      "text": "Biosynthesis of glycosaminoglycans involves attachment to core protein, chain elongation, and chain termination. The synthesis of these core proteins occurs in ________",
      "choices": [
        {
          "id": 1,
          "text": "Golgi apparatus"
        },
        {
          "id": 2,
          "text": "Endoplasmic reticulum"
        },
        {
          "id": 3,
          "text": "Mitochondria"
        },
        {
          "id": 4,
          "text": "Lysosomes"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>Biosynthesis of Glycosaminoglycans involves attachment to core Protein, chain Elongation, and chain Termination. The synthesis of these core proteins occurs in the&nbsp;<strong>Endoplasmic reticulum.</strong></p>\n<p>Synthesis of GAG:</p>\n<ul>\n<li>Synthesis of the core proteins: Endoplasmic reticulum</li>\n<li>Biosynthesis of glycosaminoglycan chains and their subsequent modifications: Golgi apparatus</li>\n</ul>\n<p>Glycosaminoglycans or mucopolysaccharides are complex carbohydrates made up of <strong>amino sugars and uronic acids</strong>. They may be attached to a protein molecule to form a proteoglycan. Proteoglycans are components of the ground substance of connective tissue. Proteoglycans have a <strong>bottle brush appearance.</strong></p>\n<p><strong>The biochemically</strong> <strong>important</strong> <strong>GAGs are as follows</strong>:</p>\n<ul>\n<li>Hyaluronic acid</li>\n<li>Chondroitin sulfate</li>\n<li>Keratan sulfate</li>\n<li>Heparin</li>\n<li>Heparan sulfate</li>\n<li>Dermatan sulfate</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD3124",
      "difficulty": "easy"
    },
    {
      "text": "The enzyme involved in the process of oxidative deamination shown in the below reaction is allosterically activated by ______",
      "choices": [
        {
          "id": 1,
          "text": "ATP"
        },
        {
          "id": 2,
          "text": "NADH"
        },
        {
          "id": 3,
          "text": "ADP"
        },
        {
          "id": 4,
          "text": "GTP"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Glutamate dehydrogenase</strong> is involved in the process of <strong>oxidative deamination</strong> reaction. It is allosterically <strong>activated by ADP</strong>.</p>\n<p>Transfer of amino nitrogen to &alpha;-ketoglutarate forms glutamate. Hepatic glutamate dehydrogenase (GDH), which can use either NAD+ or NADP+, releases this nitrogen as ammonia.</p>\n<p>Conversion of &alpha;-amino nitrogen to ammonia by the action of glutamate aminotransferase and GDH is often termed &ldquo;<strong>transdeamination</strong>.&rdquo;&nbsp;</p>\n<p>Liver GDH activity is allosterically inhibited by ATP, GTP, and NADH, and is activated by ADP.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/5ead5ccdd3404daba2c1ac8d84e4128bx1280x723.JPEG\" alt=\"Explanation Image\">",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/72980c75f2f042e59acd7432c6d4526c.PNG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD4966",
      "difficulty": "medium"
    },
    {
      "text": "Type of odor seen in multiple carboxylase deficiency  is:",
      "choices": [
        {
          "id": 1,
          "text": "Swimming pool odour"
        },
        {
          "id": 2,
          "text": "Burnt sugar odour"
        },
        {
          "id": 3,
          "text": "Tomcat urine odour"
        },
        {
          "id": 4,
          "text": "Boiled cabbage odour"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Tomcat urine odour</strong> is seen in&nbsp;<strong>multiple carboxylase deficiency</strong>.</p>\n<p>Multiple carboxylase deficiencies leads to <strong>defects in utilisation of biotin</strong>. In neonatal form of the disease, <strong>clinically, </strong>the affected infants seem normal at birth, but develop breathing difficulties shortly after birth with feeding problems, vomiting, and hypotonia. If untreated, generalized erythematous rash, exfoliation, alopecia, failure to thrive, seizures and even coma may occur. Affected infants should be treated with biotin.</p><hr><h3>Related Pearl: Inborn Errors of Amino Acid Metabolism and Their Associated Urine Odor</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Inborn Error of Metabolism</strong></p>\n</td>\n<td>\n<p><strong>Urine Odor</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Maple syrup urine disease</p>\n</td>\n<td>\n<p>Maple syrup</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hawkinsinuria</p>\n</td>\n<td>\n<p>Swimming pool</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>3-Hydroxy-3-methylglutaric aciduria</p>\n</td>\n<td>\n<p>Cat urine</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Isovaleric acidemia</p>\n<p>Glutaric acidemia (type II)</p>\n</td>\n<td>\n<p>Sweaty feet</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hypermethioninemia</p>\n<p>Tyrosinemia</p>\n</td>\n<td>\n<p>Boiled cabbage</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Multiple carboxylase deficiency</p>\n</td>\n<td>\n<p>Tomcat urine</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Phenylketonuria</p>\n</td>\n<td>\n<p>Mousy</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Trimethylaminuria</p>\n</td>\n<td>\n<p>Rotting fish</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Oasthouse syndrome</p>\n</td>\n<td>\n<p>Dried malt/hops</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC6277",
      "difficulty": "medium"
    }
  ]
}